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“Now this is not the end. It is not even the beginning of 
the end. But it is, perhaps, the end of the beginning.” 
Sir Winston Churchill 
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ABSTRACT 
 
 
 
 
Neurogenesis prevails in the adult mammalian CNS. New neurons are constitutively 
formed in-vivo in the subventricular zone (SVZ) of the lateral ventricle wall and in the 
subgranular zone of the dentate gyrus. However, other regions along the entire 
neuroaxis have been found to harbor cells with the ability to form neurospheres, self-
renew and differentiate into neurons, oligodendrocytes and astrocytes. 
Adult rodents were subjected to axotomies of the hypoglossal nerve (n.XII) followed 
by assessment of the endogenous neural progenitor cell (NPC) response and the fate of 
grafted adult eGFP SVZ NPCs in the brainstem. Sox2 expressing endogenous NPCs 
were abundant in the ependymal region of the central canal and 4th
Differences in activation after the two types of axotomies were correlated to levels of 
motor neuron death in the nucl.XII, and hence differences in the microenvironment 
with regards also to levels of free radicals and inflammatory compounds.  
 ventricle and 
activated after n.XII avulsion injury, which induced massive loss of motor neurons, but 
not after transection where the cell loss was minimal. Activation included NPC 
proliferation and subsequent migration to the hypoglossal nucleus (nucl.XII) where 
they expressed astrocytic markers. However, neurogenesis failed and no 
neuroprotective effect on motor neurons was observed. Therefore, a transplantation 
model was developed; SVZ NPCs were harvested from inbred eGFP transgenic 
animals and cells grafted to the nucl.XII of their wt siblings after n.XII injuries. The 
SVZ NPCs from transgenic animals where characterized in-vitro prior to grafting, and 
found to have same NPC characteristics as cells from wt animals. Upon transplantation 
after avulsion injury NPCs survived, differentiated into neurons, oligodendrocytes and 
astrocytes and integrated with the host circuitry. Grafted NPCs expressed VEGF and 
GPx1 that after avulsion exerted a neuroprotective effect on motor neurons. Moreover, 
we suggest that GPx1 expression contributed to the survival of transplanted cells in the 
nucl.XII post avulsion. This was in contrast to the results on grafting after transection 
since NPCs did not survive to the same extent and only differentiated into cells with 
astrocytic phenotype. Also, some of the cells continued to express Sox2. The cells did 
not integrate and no neuroprotective effects were found.  
The beneficial effects after grafting post avulsion initiated the development of an 
autologous transplantation model where the distribution of NPCs in the filum terminale 
was investigated. Sox2 and Mushasi-1 expressing cells in the human filum terminale 
were found, i.e. cells expressing NPC markers. The cells were abundant and when 
isolated and propagated in-vitro they formed neurospheres, proliferated and 
differentiated into neurons and glia. Clonal expansion indicated a relatively strong self-
renewal capacity. The cells responded to the addition of PDGF-BB with an increase in 
neuronal cell numbers.  
 
In summary, the findings suggest a repair strategy based on transplantation of adult 
NPCs in neural repair after severe motor nerve injuries. The filum terminale is a 
potential source of NPCs in future autologous cell therapies, even in human. 
 
Key words: brainstem, filum terminale, ependymal layer, subventricular zone, neural 
progenitor cells, nerve injury, motor neurons, transplantation, differentiation, 
integration 
  
 
  
LIST OF PUBLICATIONS 
 
 
 
 
 
 
This thesis is based on the following papers, which will be referred to in the text by 
their Roman numerals: 
 
 
I.  Michael Fagerlund, Nasren Jaff, Alexandre I. Danilov, Inti Peredo, Lou 
Brundin and Mikael Svensson 
Proliferation, migration and differentiation of ependymal region neural 
progenitor cells in the brainstem after hypoglossal nerve avulsion. 
Restorative Neurology and Neuroscience 2011, 29(1):47-59 
 
 
 
II.  Michael Fagerlund, Cynthia Pérez Estrada, Nasren Jaff, Mikael Svensson and 
Lou Brundin 
Neural stem/progenitor cells transplanted to the hypoglossal nucleus 
integrates with the host CNS in adult rats and promotes motor neuron 
survival. 
Cell Transplantation 2012, 21(4):739-747 
 
 
 
III.  Michael Fagerlund, Cynthia Pérez Estrada, Nasren Jaff, Lou Brundin and 
Mikael Svensson 
Integration differences of transplanted neural progenitors in two models 
of axotomy. 
Manuscript 
 
 
 
IV.  Lisa Arvidsson, Michael Fagerlund, Nasren Jaff, Amina Ossoinak, Katarina 
Jansson, Anders Hägerstrand, Clas B. Johansson, Lou Brundin and Mikael 
Svensson 
Distribution and characterization of progenitor cells within the human 
filum terminale. 
PLoS One 2011, 6(11):e27393 
 
  
 
  
CONTENTS 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION   ............................................................................................. 1
1 DEVELOPMENTAL NEUROGENESIS   ............................................... 1
2 NEUROGENESIS IN THE ADULT   ....................................................... 3
2.1 Neurogenic Regions   ..................................................................... 3
2.2 Non-Neurogenic Regions   ............................................................. 5
2.3 Identifying the Progenitor Cell   .................................................... 7
3 PERIPHERAL NERVE INJURY   ............................................................ 9
3.1 Retrograde and Anterograde Degeneration   ................................. 9
3.2 Factors Affecting Degeneration   ................................................. 11
3.3 Transmission vs. Growth   ........................................................... 13
3.4 Regeneration and Microsurgical Repair   .................................... 14
4 THE HYPOGLOSSAL NERVE MODEL   ............................................ 15
5 TRANSPLANTATIONS   ........................................................................ 16
AIMS OF THE STUDY   .................................................................................. 19
MATERIAL AND METHODS   ..................................................................... 21
1 ANIMAL EXPERIMENTS   .................................................................... 21
1.1 Labeling of Cells in The Ependymal layer (Paper I)   ................ 21
1.2 BrdU Injections (Paper I)   .......................................................... 21
1.3 Hypoglossal Nerve Injury (Papers I, II and III)  ........................ 22
1.4 Cell Preparation (Papers II, III and IV)   ..................................... 22
1.5 Transplantations (Papers II and III)   .......................................... 23
2 HUMAN MATERIAL   ............................................................................ 23
3 EXPERIMENTAL GROUPS   ................................................................. 25
3.1 Paper I   ......................................................................................... 25
3.2 Paper II   ........................................................................................ 25
3.3 Paper III   ...................................................................................... 26
3.4 Paper IV   ...................................................................................... 26
4 TISSUE PROCESSING   ......................................................................... 27
4.1 Animal Tissue (Papers I, II, III and IV)   .................................... 27
4.2 Human Tissue (Paper IV)   .......................................................... 27
5 IMMUNOHISTOCHEMISTRY   ............................................................ 27
6 MICROSCOPY AND QUANTIFICATION   ......................................... 29
6.1 Confocal Microscopy (Papers I, II, III and IV)  ......................... 29
6.2 Widefield Microscopy (Papers I, II, III and IV)   ....................... 30
6.3 Cell Counting (Papers I, II and III)   ........................................... 30
7 STATISTICAL ANALYSIS   .................................................................. 30
  
SUMMARY OF RESULTS   ............................................................................ 31
1 MOTOR NEURON CELL LOSS   .......................................................... 31
2 INFLAMMATORY AND GLIA CELL RESPONSE  ........................... 31
3 ENDOGENOUS PROGENITOR CELL ACTIVATION   ..................... 32
4 TRANSPLANTATIONS   ........................................................................ 33
4.1 Characterization of Subventricular Zone Progenitor Cells   ....... 33
4.2 Viability of Cells Prior to Transplantation  ................................. 33
4.3 Survival, Differentiation and Integration of Cells   ..................... 33
4.4 Effects on Motor Neuron Survival   ............................................. 34
5 PROGENITOR CELLS IN THE FILUM TERMINALE   ..................... 35
5.1 Distribution   ................................................................................. 35
5.2 In-vitro Characterization   ............................................................ 35
DISCUSSION   ................................................................................................... 39
1 INTRODUCTION TO DISCUSSION   ................................................... 39
2 ENDOGENOUS PROGENITOR CELLS   ............................................. 41
2.1 Distribution   ................................................................................. 41
2.2 Proliferation   ................................................................................ 43
2.3 Migration and Differentiation   .................................................... 44
3 GRAFTED ADULT PROGENITOR CELLS   ....................................... 46
4 ACTIVATION OF THE PROGENITOR CELLS   ................................ 48
5 PROGENITOR CELLS IN THE FILUM TERMINALE   ..................... 51
6 TREATMENT STRATEGIES AFTER AVULSION INJURIES   ........ 54
6.1 Endogenous Neural Progenitor Cell Activation   ........................ 54
6.2 Grafting of Adult Neural Progenitor Cells   ................................ 55
6.3 Root and Nerve Implantations   ................................................... 56
6.4 Combinational Therapies   ........................................................... 57
6.5 Timing of Treatment  ................................................................... 57
7 CONCLUDING REMARKS   .................................................................. 58
CONCLUSIONS   .............................................................................................. 59
ACKNOWLEDGEMENTS   ............................................................................ 60
REFERENCES   ................................................................................................ 64
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 ABBREVIATIONS 
 
 
 
 
 
 
 
 
 
bFGF  Basic fibroblast growth factor 
BMP  Bone Morphogenic Proteins  
BDNF  Brain-derived neurotrophic factor 
BrdU 5-Bromo-2´-deoxyuridine 
CSC  Cancer stem cell 
CD133  Cluster of differentiation 133 
ChAT  Choline acetyltransferase 
CNTF  Ciliary neurotrophic factor  
CNS Central nervous system 
CSF Cerebrospinal fluid 
EAE Experimental autoimmune encephalomyelitis 
EGF Epidermal growth factor 
eGFP  Enhanced green fluorescent protein 
FGF  Fibroblast growth factor 
FT  Filum terminale 
GDNF  Glial cell line-derived factor 
GFAP  Glial fibrillary acidic protein 
GLAST  Glutamate aspartate transporter 
IGF  Insulin growth factor 
JAK  Janus Kinase 
iNOS  Inducible nitric oxide synthase 
LIF  Leukemia inhibiting factor 
MS  Multiple sclerosis 
n.XII  Hypoglossal nerve 
nNOS  Neuronal nitric oxide synthase 
NGF  Neural growth factor 
nucl.XII  Hypoglossal nucleus 
NO  Nitric oxide 
NOS  Nitric oxide synthase 
NPC Neural progenitor cell 
PDGF Platelet-derived growth factor   
PNS Peripheral nervous system 
RNOS  Reactive nitric oxide species 
ROS  Reactive oxygen species  
RMS  Rostral migratory stream 
SGZ  Subgranular zone 
Shh  Sonic hedgehog 
  
Sox2 Sex determining region of Y-chromosome (SRY)-related HMG-box 2 
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INTRODUCTION 
 
 
 
 
 
 
 
 
 
Adult neurogenesis is today an accepted phenomenon of mammalian neurobiology. 
This, the firm establishment of the generation and development of new neurons in the 
adult central nervous system (CNS), was by The New York Times found to be the one 
finding that stood out as the most startling research result from the 1990-1999 “Decade 
of the Brain” (Blakeslee 2000).  
In 1992 Brant A. Reynolds and Samuel Weiss published the first in-vitro evidence of 
adult neurogenesis when they induced cells isolated from the striatum of adult mice 
brain to proliferate and develop morphological and antigenic properties of neurons and 
astrocytes (Reynolds and Weiss 1992). Although this study was of uttermost 
importance as evidence for adult neurogenesis, some pioneering work was done already 
during the 1960´s by Joseph Altman which was later extended by Michael Kaplan and 
also by Fernando Nottebohm, which provided substantial evidence for the formation of 
new neurons in the adult (Altman 1962; Altman 1963; Altman and Das 1965; Kaplan 
and Hinds 1977; Goldman and Nottebohm 1983; Paton and Nottebohm 1984).  
These findings contributed to the end and cessation of the “no neurogenesis dogma”.  
A dogma that prevailed for 100 years, posed by the founding fathers of neuroscience 
and exemplified by Santiago Ramón y Cajal when he in his 1913 Estudios sobre la 
degeneración y regeneración del sistema nervioso concluded that “In adult centers, the 
nerve paths are something fixed, ended, immutable. Everything may die, nothing may 
be regenerated” (Ramón y Cajal 1928).  
This has now changed and adult neurogenesis is established in rodent and non-human 
primate, findings show that it is also prevailed in the adult human CNS although this is 
to some extent debated (Eriksson et al. 1998; Curtis et al. 2007; Sanai et al. 2007; Sanai 
et al. 2011; Wang et al. 2011).  
 
 
1 DEVELOPMENTAL NEUROGENESIS 
 
The development of the nervous system commences when the mesoderm induces 
ectodermal cells to become lineage restricted as neural stem and progenitor cells, 
making the ectodermal cells specified as neural instead of non-neural epidermal cells – 
a process known as neural induction (Donkelaar et al. 2006). Hereby the neural plate, 
and subsequently the neural tube are formed. The neural tube is at first constituted by a 
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single layer of proliferating neuroepithelial cells that have the ability to give rise to all 
the neuronal and glial cell types in the developing CNS (Gotz and Huttner 2005). The 
neuroepithelial cells are highly polarized along their apical-basal axis, they express 
CD133, a transmembrane protein found in the apical plasma membrane, the 
intermediate filament Nestin and the Sex Determining Region of Y chromosome 
(SRY)-related HMG-box
Williams and Price 1995
 proteins 1, 2 and 3 (i.e. Sox1, Sox2 and Sox3) which act as 
transcription factors ( ; Weigmann et al. 1997; Bylund et al. 
2003; Graham et al. 2003; Gotz and Huttner 2005).  
In the first phase of neural development these cells continuously divide, initially 
symmetrically, resulting in the formation of the primary proliferative and first 
germinative zone, the ventricular zone (VZ), which constitutes the wall of the 
primordial ventricle (Huttner and Brand 1997; Gotz 2003). This first proliferative phase 
and the length of it is considered to be the determinant for the given size of a specific 
brain region since this gives rise to a high or low number of precursor cells, and thus 
the onset of neurogenesis in time is influential for regional size.  
At the onset of neurogenesis, the second phase, the neuroepithelial cells gives rise to 
the radial glia cells which are one of the earliest cell types to differentiate (Hartfuss et 
al. 2001; Fishell and Kriegstein 2003; Gotz and Huttner 2005). These cells extend from 
the luminal to the pial side in the developing CNS and functions both as precursor for 
neurons and glia and as guidance cells for newly generated neurons, leading them from 
the region of proliferation near the ventricular surface to their final position in the 
cortex.  
The radial glia constitute the majority of precursors in the VZ and are distinguished 
from the neuroepithelial cells, as the name implies, by the development of glial 
characteristics. These include the appearance of glycogen granules, expression of glial 
fibrillary acidic protein (GFAP), glutamate aspartate transporter (GLAST) and brain-
lipid-binding protein (BLBP) (Hartfuss et al. 2001; Zecevic 2004). However, some of 
the neuroepithelial characteristics are maintained e.g. an apical surface and apical-basal 
polarity and the expression of Sox2, Nestin and CD133 (Hockfield and McKay 1985; 
Weigmann et al. 1997; Chenn et al. 1998; Hartfuss et al. 2001; Graham et al. 2003; 
Ellis et al. 2004). The radial glia are more fate restricted than the neuroepithelial cells 
and most of them give rise to a single cell type in the CNS i.e. neurons, 
oligodendrocytes or astrocytes (Gotz and Huttner 2005).  
The symmetric cell division in the first phase is followed by asymmetric division, and a 
secondary proliferative layer is formed, the subventricular zone (SVZ) (Huttner and 
Brand 1997; Gotz and Huttner 2005). Basal progenitors, which originate from 
neuroepithelial and radial glia cells, contribute to the formation of this layer basal to the 
VZ. This secondary layer is present in the adult CNS as the SVZ of the lateral ventricle 
wall (Doetsch et al. 1997).  
Neurogenesis is followed by the third phase, gliogenesis, where a distinctive expansion 
of the SVZ, which now contains many glial precursors, is seen. In the postnatal period 
the VZ is reduced in size in a progressive matter to eventually disappear and is in the 
adult replaced by the ependymal cell layer, although it is argued that a VZ is also 
contained within the adult germinal niche of the lateral ventricle wall (Ihrie and 
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Alvarez-Buylla 2011). The ependymal cells are also considered to be derived from 
radial glia (Spassky et al. 2005).   
 
 
2 NEUROGENESIS IN THE ADULT  
 
Adult neurogenesis is the production of new neurons in the adult CNS, which means 
that one, or a plethora, of neural stem, progenitor and/or precursor cells has to exist. 
The question is where, what, why and how? 
 
 
2.1 Neurogenic Regions  
 
Neurogenesis in the adult is not the same as neurogenesis during development. 
The information regarding position and patterning, conditions, starting points, the cells 
involved and the time course differ. However, knowledge about developmental 
neurogenesis is fundamental in order to comprehend the many aspects of adult 
neurogenesis and the links from the embryological and fetal cells, signals and events 
are obvious (Fishell and Kriegstein 2003; Gotz 2003; Gritti and Bonfanti 2007). For 
example, postnatal CNS development continues in the cerebellum and hippocampus 
although this has to be clearly set apart from adult neurogenesis.  
In the adult there are two regions where neural stem or progenitor cells are present in a 
milieu, or niche, which allows for new neurons to be formed; the SVZ in the lateral 
ventricle wall and the subgranular zone (SGZ) in the dentate gyrus in the hippocampus 
(Riquelme et al. 2008; Ihrie and Alvarez-Buylla 2011; Ming and Song 2011). These are 
the neurogenic niches in the adult brain where neurogenesis prevails under normal 
physiologic conditions.  
Cells from these two neurogenic regions can be isolated, form neurospheres, self-
renew, express phenotypic markers for stem or progenitor cells and differentiate into 
neurons, oligodendrocytes and astrocytes. They have been studied extensively in in-
vitro models, originally described by Reynolds and Weiss and further characterized by 
others (Reynolds and Weiss 1992; Morshead et al. 1994; Reynolds and Weiss 1996; 
Gritti et al. 1999). These in-vitro characteristics have been the basis and golden 
standard for research on adult neurogenesis in general, and more specifically research 
on identifying the true, if there is one, stem cell of adult neurogenesis. Thus, it is 
important to stress that culture conditions can affect cell characteristics and there are 
several reports on cells which appear to be neural stem or progenitor cells in culture, 
but in-vivo fail to fulfill the criteria (Goritz and Frisen 2012). On the other hand, the 
failure of neuronal differentiation does not per se mean that a response is of no use 
since the cell needed in a particular instance could very well be, for example, an 
astrocyte.  
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Subventricular zone  
 
The SVZ in the wall of the lateral ventricle is the largest region of neurogenesis in the 
adult mammalian brain. Cells from here migrate from their position in the SVZ, via the 
anatomical structure known as the rostral migratory stream (RMS), in a migration 
called chain migration to the olfactory bulb where they generate inhibitory olfactory 
bulb interneurons (Doetsch and Alvarez-Buylla 1996; Lois et al. 1996; Curtis et al. 
2007).  
The architecture of the SVZ in the adult was originally described by Arturo Alvarez-
Buylla and his group in 1997, and consists of four major cell types; 1) the slowly 
dividing GFAP-positive SVZ-astrocyte (Type B cell) which is considered to function as 
the primary neural stem/progenitor cell in the adult, 2) the rapidly dividing transit-
amplifying cell (Type C cell) which functions as a precursor cell, this cell is also 
sometimes referred to as the intermediate precursor cell, 3) the migrating neuroblast 
(Type A cell) which is derived from the type C cell and migrates along the RMS to the 
olfactory bulb for terminal differentiation and 4) the ependymal cell (Doetsch et al. 
1997).  
The complexity of this region extends beyond these cells since several other 
components and factors contribute to, and are significant for, the features and function 
of neurogenesis in this neurogenic niche.  
These other constituents involve microglia, the vasculature including endothelial cells, 
fibroblasts, cerebrospinal fluid (CSF), extracellular matrix proteins, gap-junctions, 
basal lamina, extrinsic signaling pathways e.g. growth factors, intracellular acting 
molecules e.g. transcription factors and neurotransmitters e.g. GABA signaling 
(Coskun et al. 2008; Riquelme et al. 2008; Ihrie and Alvarez-Buylla 2011; Ekdahl 
2012). Furthermore, this niche has been found to be heterogeneous as the 
stem/progenitor cells in different locations give rise to distinct progeny in the form of 
different types of neurons.    
As mentioned above the SVZ is a remnant of the embryonic SVZ and the multiciliated 
ependymal cells replaces the psuedostratified epithelium of the VZ turning it into a 
simple columnar epithelium lining the ventricle wall. During the years there has been a 
discussion about the identity of the primary neural stem/progenitor cell in the adult 
SVZ and many papers have dealt with the quest of presenting evidence enough for a 
general acceptance of its nature. Jonas Friséns group demonstrated that this cell would 
be the ependymal cell, this was however argued by others and Arturo Alvarez-Buylla 
and colleagues in his lab presented evidence showing that this cell was instead the type 
B astrocyte-like cell of the SVZ (Doetsch et al. 1999; Johansson et al. 1999). The latter 
has been supported in additional studies, and the GFAP-positive type B cell is more or 
less considered to be the “true” stem/progenitor cell in this neurogenic region of the 
adult nervous system. The type B cells have been found to have apical processes that 
penetrates the ependymal layer which makes this cell, as well as the ependymal cell, to 
be in contact with the CSF (Doetsch et al. 2002; Ihrie and Alvarez-Buylla 2011; 
Kokovay et al. 2012). Furthermore, it was suggested that the ependymal cells are born 
in the embryonic and early postnatal brain and after differentiation are postmitotic, and 
do not contribute to neurogenesis during normal physiologic conditions (Spassky et al. 
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2005; Carlen et al. 2009). Although the, also radial glia derived, ependymal cell is 
proposed to possess neural stem cell characteristics in the adult (Coskun et al. 2008).    
Whether neurogenesis is continuously ongoing in the SVZ also in the adult human 
CNS is debated and it appears that the SVZ of the adult human brain differs from the 
SVZ of the non-human mammalian brain, however there are some evidence favoring 
neurogenesis also in man (Curtis et al. 2007; Sanai et al. 2007; Sanai et al. 2011; Wang 
et al. 2011).  
 
 
Dentate gyrus  
 
The second neurogenic region of the adult CNS is the dentate gyrus of the 
hippocampus. Also here the link to development is present as a radial glia-like cell in 
the SGZ is the putative stem/progenitor cell of this niche. From these quiescent cells 
intermediate precursors and subsequently neuroblasts are formed which, together with 
immature neurons, migrate to the inner granule cell layer where they differentiate into 
excitatory dentate granule cells that are generated and integrated into the existing 
circuitry throughout life (Eriksson et al. 1998; Filippov et al. 2003; Ming and Song 
2011; Encinas and Sierra 2012).  
In this part of our nervous system declarative information is processed and consolidated 
by relating items in space and time, thus enabling memory to be episodic and 
neurogenesis in the SGZ has, interestingly enough, been shown to be affected by 
factors such as physical exercise, enrichment of the milieu surrounding the individual 
and stress (Gould et al. 1997; Kempermann et al. 1998; van Praag et al. 1999; Aimone 
et al. 2011; Ming and Song 2011). 
Regarding this neurogenic region adult neurogenesis can be considered established also 
in the human, although it appears to be sparse (Eriksson et al. 1998; Goritz and Frisen 
2012). 
Since this region, although highly dynamic and interesting, is not the focus for this 
study the interested reader is referred to the literature cited for further reading.   
 
 
2.2 Non-Neurogenic Regions  
 
In most regions of the adult CNS neurogenesis does not occur. The neurogenic regions 
are defined by a germinative matrix where neurogenesis persist throughout life, and 
during normal physiological conditions the SVZ and the SGZ are the only parts of the 
adult CNS where this occurs. Nonetheless, other regions along the entire neuroaxis 
have been found to harbor cells with the ability to form neurospheres, self-renew and 
differentiate into neurons, oligodendrocytes and astrocytes. 
 
 
Ependymal region of the 4th 
 
ventricle and central canal 
The ciliated columnar ependymal cell originates from the radial glia cell and forms an 
ependyma i.e. epithelial monolayer lining the surface of the CSF containing ventricles 
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and the central canal, and plays important functions in adult neurogenesis as part of the 
neurogenic niche in the SVZ, e.g. for integrity of the niche and in pathway signaling 
(Sturrock and Smart 1980; Spassky et al. 2005; Gritti and Bonfanti 2007; Barnabe-
Heider et al. 2008; Coskun et al. 2008; Morrens et al. 2012).  
The ependymal cell is considered quiescent and seem not to contribute to neurogenesis 
under normal physiological conditions in the SVZ niche, although others suggest 
different (Spassky et al. 2005; Coskun et al. 2008; Carlen et al. 2009; Ihrie and 
Alvarez-Buylla 2011). That is, it does not contribute by means of vast proliferation and 
differentiation.  
The ependyma is demonstrated to be replaced in models of ependymal depletion which 
would indicate that ependymal cells are not post-mitotic and do divide in the adult, 
however findings show that this is accomplished by dividing SVZ astrocytes which 
incorporate within the ependyma where they develop characteristics of ependymal cells 
(Spassky et al. 2005; Luo et al. 2006; Luo et al. 2008; Nomura et al. 2010). 
Interestingly, it is also found that ependymal cells can convert to astrocytes and that the 
majority of the SVZ astrocytes that are incorporated in the ependymal layer for 
ependyma maintenance derive from ependymal cells, an interconversion which seems 
to occur without cell division (Nomura et al. 2010). 
Thus, the quiescent ependymal cell is indeed plastic and of the uttermost importance for 
SVZ neurogenic niche maintenance and function, furthermore it is shown to give rise to 
both neuroblasts and astrocytes in the forebrain during pathological conditions e.g. 
stroke (Carlen et al. 2009). Importantly, the ependymal cell in the central canal have 
been found to proliferate also in the uninjured setting, however also in this part of the 
CNS they are considered a quiescent population of very slowly dividing cells which 
self-duplicates only in order to maintain their populations in the ependymal layer 
(Hamilton et al. 2009; Barnabe-Heider et al. 2010).  
But more important, ependymal cells of the fourth ventricle and central canal region of 
the brainstem and spinal cord have been reported to proliferate, migrate and 
differentiate upon spinal cord injury and inflammatory disease (Johansson et al. 1999; 
Brundin et al. 2003; Mothe and Tator 2005; Danilov et al. 2006; Meletis et al. 2008; 
Cizkova et al. 2009; Barnabe-Heider et al. 2010; Foret et al. 2010). The ependymal cell 
of this region is also shown to respond to non-pathological physiological stimulation 
(Cizkova et al. 2009; Foret et al. 2010).  
Thus, although maybe not considered to be the cell from which all adult neurogenesis 
originates, the ependymal cell has been shown to possess neural stem or progenitor cell 
abilities in-vitro, and also in-vivo following injury and disease.   
 
 
Filum terminale 
 
Since cells around the central canal possess multipotent progenitor cell abilities, interest 
was raised in the filum terminale (FT) for investigations regarding adult neurogenesis 
and potential use in regenerative medicine.  
The FT is a structure that extends from the conus medullaris to the coccyx. It has 
generally been considered to be a fibrous structure with longitudinal arrangement of 
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collagen bundles and large amounts of elastic fibers giving it considerable elastic 
properties, with its main clinical significance in the stretch induced functional disorder; 
tethered cord syndrome (Fontes et al. 2006; Liu et al. 2011). However, findings also 
suggested that the FT was a continuation of the spinal cord with an ependyma-lined 
central canal, neurons and glia cells and the question whether the small sized neurons 
found could represent neurons in an early phase was raised (Choi et al. 1992; Rethelyi 
et al. 2004; Fontes et al. 2006). The development of the FT involves the process of 
secondary neurulation where amongst other events the neuroepithelial cells of the 
primitive spinal cord subsequently are substituted after a sequence of aggregation and 
apoptosis (Nievelstein et al. 1993; Salbacak et al. 2000).  
The FT is thus a much more complex structure than a fibrous streak and it has been 
shown that the adult human FT contains progenitor cells that in-vitro self-renew, 
proliferate to form neurospheres and express phenotypic markers for neurons, 
oligodendrocytes and astrocytes and also develop the electrophysiological profile of 
neurons and glia (Varghese et al. 2009).   
 
 
Parenchyma of the spinal cord 
 
As adult spinal cord cells in culture responded to epidermal growth factor (EGF) and 
basic fibroblast growth factor (bFGF) by proliferation and differentiation into neurons 
and glia, it was concluded that neural stem/progenitor cells were present also within 
here (Weiss et al. 1996; Shihabuddin et al. 1997). Although not fully characterized 
these parenchyma cells have been reported also in-vivo and found to express markers 
associated with neural stem or progenitor cells and to respond to injury and disease 
(Horner et al. 2000; Azari et al. 2005; Ohori et al. 2006). Thus, in addition to cells in 
the ependymal layer, stem/progenitor cells are present also in the parenchyma. 
Although not being the focus or examined in detail in the work of this study, 
knowledge of their existence is of importance when investigating neural 
stem/progenitor cells in the brainstem. However, these cells seem not to be as 
proliferative and multipotent as the ependymal cell from the central canal (Martens et 
al. 2002; Ohori et al. 2006; Meletis et al. 2008). 
The spinal cord environment is in general gliogenic i.e. it is inhibitory to neuronal 
differentiation and the regeneration of axons in the CNS is hindered by the constituents 
in this particular niche, thus neural stem/progenitor cells are found to give rise mainly 
to glia and only limited numbers of neurons after both transplantation and endogenous 
activation (Cao et al. 2001; Ohori et al. 2006; Parr et al. 2007). This gliogenic feature of 
the spinal cord is supported by transplantation experiments where cells transplanted to 
the hippocampus generated neurons whereas the same cells grafted to the spinal cord 
generated cells of glial nature (Shihabuddin et al. 2000). 
 
 
2.3 Identifying the Progenitor Cell 
 
The use of the term stem cell in adult neurogenesis is somewhat confusing and 
controversial. Therefore, it is not overwhelmingly hard to understand why researchers 
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within the field compares the difficulties on defining an adult neural stem cell to the 
frequently quoted remark made by U.S. Supreme Court Justice Byron White on 
something completely different: “It is hard to define, but I know it when I see it” 
(Morrison et al. 1997). When I first entered the world of adult neurogenesis and 
commenced my scientific work this was kind of how I experienced it. I intuitively 
knew what an adult neural stem cell was. Or, to be honest, I thought I knew.  
Not to be forgotten is that many conclusions regarding the identity, and whole nature, 
of the neural stem or progenitor cell have to be drawn from in-vitro experiments and in-
vitro data. This means that the identification of features of a cell involved in adult 
neurogenesis are, at least to some extent, dependant on the methods applied. 
 
 
Phenotypic markers 
 
In order to conduct research on adult neurogenesis it is crucial to identify the adult 
neural stem or progenitor cell.  
For this a number of markers have been found to be expressed by such a cell, of which 
many obviously are found in stem, progenitor and precursor cells during development 
as previously discussed. Two of these markers, which are used when conducting 
research on adult neurogenesis, are the type VI intermediate filament Nestin and the 
transcription factor Sox2 (Doetsch et al. 1997; Filippov et al. 2003; Ellis et al. 2004; 
Komitova and Eriksson 2004; Mothe and Tator 2005; Baer et al. 2007). Other markers 
used for identifying adult neural stem/progenitor cells are the neural RNA-binding 
protein Musashi-1, the transmembrane protein Notch1 which signaling pathway is 
important in maintaining a stem/progenitor cell state and inhibiting neuronal 
differentiation, the adhesion and signaling molecule vascular endothelial adhesion 
molecule-1 (VCAM1), identified as a key molecule responsible for maintaining the 
neurogenic niche and GFAP, which of course is not restricted to stem or progenitors, 
but is also one of the key features for astrocytes (Doetsch et al. 1997; Kaneko et al. 
2000; Stump et al. 2002; Kokovay et al. 2012). 
Importantly, no single marker stands out as the specific marker for identifying adult 
neural stem or progenitor cells. For example Nestin is for sure expressed by these cells, 
but also by reactive astrocytes and cannot be used as an exclusive marker. Instead a 
combination of expression of various markers has to be used, which also might reflect 
the heterogenic character of this cell and cell niche. 
 
 
Defining the neural progenitor cell 
 
By strict definition a stem cell should be totipotent, i.e. it should not only have the 
capability to differentiate into all the specialized cells in an organism, but also be able 
to give rise to cells and tissue outside of the embryo, however associated with the 
embryo (i.e. the trophoblast). This cell, the zygot, the mother of all stem cells, is a true 
stem cell and can give rise to a complete new organism. 
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When working on adult neurogenesis the terms stem, progenitor and precursor cells are 
all being used, mostly for describing different cells which differs with regards to 
characteristics and “stemness”, but not always. Most neuroscientists generally accept 
that the term adult neural stem cell include cells that are “only” pluri or multipotent and 
that the term progenitor cell might be used equipotent. It is important to stress that the 
cell must fulfill the basic criteria including ability to self-renew and differentiate to one 
or more types of specialized daughter cells, this could be both by symmetric and 
asymmetric cell division. More strict developmental definitions gives that this cell 
should be a cell that self-renews during the lifetime of the organism, to exclude 
transient precursors, and that the term progenitor cell should be used to describe a cell 
with limited self-renewal and with somewhat limited stem cell properties, for reviews 
see (Weissman et al. 2001; Seaberg and van der Kooy 2003).  
In this thesis the term neural progenitor cell (NPC) will be used. By this I refer to a cell 
that, within the adult CNS, has the ability to self-renew and give rise to neurons, 
oligodendrocytes and astrocytes. Whether this cell has the ability to unlimited self-
renewal and the potential to generate, if not all, but at least multiple cell-lineages within 
the organism is not stated – hence the term progenitor cell rather than stem cell. Neither 
do I claim to have identified the exact identity, nature nor feature of a cell from which 
adult neurogenesis originates. This is a quest prevailed by many others and for which 
the answer is not yet given. However, when working in the field of adult neurogenesis 
and drawing conclusions from experimental work, this heterogeneity is important to 
bear in mind.   
 
 
3 PERIPHERAL NERVE INJURY 
 
The peripheral nervous system (PNS) is composed of the spinal nerves and roots, the 
peripheral nerves, autonomic fibers in the periphery and also the cranial nerves. Within 
the scope of the investigations and results presented herein, only the motor peripheral 
nervous system will be discussed. 
The motor neurons in the PNS (i.e. the lower motor neurons) have their cell bodies 
located in the spinal cord or in the brainstem in the CNS. The axons of these motor 
neurons initially run a short distance within the CNS passing the interface to the PNS to 
continue in the peripheral nerve to eventually end up in its target organ, the muscle.  
 
 
3.1 Retrograde and Anterograde Degeneration 
 
An injury to axons of motor neurons in the adult PNS induces a series of structural and 
metabolic alterations in the injured neuronal cell bodies usually referred to as the 
retrograde “axon reaction”. This was originally defined based on morphological 
characteristics including swelling of the soma, decentralization of the perikarya and 
dispersal of Nissl substance “chromatolysis”. However, retrograde changes that occur 
in the CNS following peripheral axotomy includes also a number of structural changes 
in the immediate vicinity to the affected motor neurons, including the glial cell 
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response, “gliosis” and detachment of synapses “synaptic stripping”. These retrograde 
changes in the CNS are paralleled by peripheral reorganization including disintegration 
of the disconnected distal portion of the axon, the anterograde “Wallerian” 
degeneration, Schwann cell proliferation followed by sprouting and regeneration. For 
review see (Lieberman 1974; Aldskogius 1993).  
 
The “Axon Reaction” 
 
Neuronal cell death 
The outcome following axotomy can be grouped in three principally different end 
results for the neurons; I) complete recovery, II) atrophy with partial recovery or III) 
degeneration and death. However, the degree of cell death has been suggested to be 
overestimated since the atrophy of these cells can be substantial and long lasting, and 
thus hard to find in the tissue in cell counting experiments (Kwon et al. 2002).  
Findings, initially from axotomized rubrospinal neurons and later also in motor 
neurons in the facial nucleus after facial nerve axotomy, showed that atrophied 
neuron perikarya recovered to more normal volumes following a second axotomy 
(Kwon et al. 2002; McPhail et al. 2004). This discrepancy, and perhaps 
overestimation of neuronal cell death, indicates that even after some time there are 
cells to be rescued, which were thought to be lost, i.e. treatment also in the chronic 
state after injury could be worthwhile. In addition, when assessing cell loss it is found 
that neuronal loss in for example the hypoglossal nucleus is not uniform as the loss is 
more prominent at caudal levels (Yu 1988). These results should, at least, be 
considered when evaluating results.   
The exact mechanisms leading to neuronal death are not fully understood, but it 
appears that trophic support e.g. provided from the periphery by proliferating 
Schwann cells and target contact is of fundamental importance (Carlstedt et al. 1989; 
Koliatsos et al. 1994; Li and Raisman 1994; Wu et al. 1994; Novikov et al. 1997), for 
review see (Chu and Wu 2009).   
How motor neurons die is also to some extent unclear but it is more or less concluded 
to be by both programmed, apoptotic, and by means of necrotic death (Li et al. 1998; 
Martin et al. 1999; Park et al. 2007).  
 
Detachment of synapses 
“Synaptic stripping”, coined by Kreutzberg, seems to be an important endogenous 
neuroprotective mechanism, by providing protection from the metabolic stress of 
excitotoxic transmission that may be harmful to the axotomized neuron (Blinzinger and 
Kreutzberg 1968). The removal of synapses begins early after the axotomy which is 
well documented in several publications by e.g. counting their numbers on the cell 
surface of affected neurons (Svensson et al. 1991; Svensson and Aldskogius 1993). 
Detachment of synapses are paralleled by a reduction in size of the dendritic tree 
related to down regulation of the microtubule associated protein MAP2 in the dendrites, 
loss of axon collaterals and a reduction in the diameter of the proximal part of the axon 
(Risling et al. 1983; Havton and Kellerth 1990; Svensson and Aldskogius 1992).  
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Microglia 
The glial responses in the CNS that follows a peripheral nerve injury includes 
proliferation and migration of reactive microglial cells that early in the process 
become located near the cell surface (perineuronal) of affected neurons (Svensson 
and Aldskogius 1993; Aldskogius 2001; Moran and Graeber 2004; Graeber and Streit 
2010). The microglial response seem to be an important “player” in a cascade of 
neuroinflammatory events induced not only following a peripheral nerve injury but in 
fact to any injury to the PNS/CNS, e.g. traumatic brain- and spinal cord injuries as 
well as neurodegenerative and neuroinflammatory diseases such as Parkinson´s 
disease and multiple sclerosis (MS) (Graeber and Streit 2010; Sriram 2011). 
Some of the alterations seen in reactive microglia includes induction of MHC class I 
and II antigen (Maehlen et al. 1988; Streit et al. 1989), synthesis of key factors in the 
complement system (Svensson and Aldskogius 1992; Svensson et al. 1995) as well as 
synthesis and release of free radicals (Boje and Arora 1992; Li et al. 2005).   
Microglial cells residing in the CNS are believed to be of mesodermal origin and 
descendant of the mesenchymal monocyte-macrophage family which during the 
prenatal and early postnatal period migrates into the CNS where they in the 
parenchyma transform and differentiate (Ling et al. 1980; Ling and Wong 1993). 
However, a small number of the reactive microglial cells seen after CNS-injury and 
peripheral nerve axotomy seem to be infiltrating bone-marrow derived cells (Priller et 
al. 2001; Ladeby et al. 2005).   
 
Astrocytes 
Astrocytes also have a proliferative capacity which is well documented following 
more severe injuries to the nervous system, however, following a peripheral nerve 
injury these cells only hypertrophy and fine processes of these cells become located 
between the perineuronal microglial cells and the neuronal cell membrane (Graeber 
and Kreutzberg 1986; Tetzlaff et al. 1988; Svensson et al. 1994), reviewed in 
(Aldskogius 1993; Moran and Graeber 2004).  
 
Oligodendrocytes 
Oligodendrocytes seem to be more silent without any significant metabolic or 
structural changes following peripheral nerve injury, e.g (Watson 1972; Barron et al. 
1990; Aldskogius 1993). 
 
 
3.2 Factors Affecting Degeneration 
 
The severity of the injury and thus the outcome of a peripheral nerve injury depend 
on several factors. When analyzing data from different studies concerning e.g. 
neuronal cell death following axotomy it is important not only to identify type and 
level of injury, but also several other confounding parameters such as nerve model, 
species, gender and age of experimental animals which may have significant impact 
on the results. 
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Avulsion and transection - proximal vs. distal injury 
 
Another crucial factor with impact on neuronal survival is the distance of the injury 
site to the cell body, related to the amount of trophic support by Schwann cells in the 
proximal remnant of the nerve (Li and Raisman 1994; Wu et al. 1994; Ide 1996; 
Cullheim et al. 1999; Chu and Wu 2009; Carlstedt 2011). Avulsion injury (tearing) 
usually causes proximal breaking of axons near the CNS-PNS interface or even at the 
CNS side close to the cell bodies and should thus be regarded as a CNS injury 
(Risling et al. 1983; Carlstedt et al. 1989; Risling et al. 1992). Such injury cause 
massive cell death as a result of the extreme proximity of the axotomy with total 
disconnection to the periphery (Koliatsos et al. 1994; Yu 1997; Jiang et al. 2000; 
Hoang et al. 2003). A transection injury (nerve cut) of a peripheral motor nerve leads 
to disruption of all of the components of the nerve, nonetheless such an injury is 
followed by only a low number of motor neuronal loss as long as the two nerve 
endings are in close contact, although the more proximal the injury is to the site of the 
localization of the motor neurons, and the greater the distance between the proximal 
and distal ends of the transected nerve, the more severe consequences will follow 
(Svensson and Aldskogius 1993; Yu 1997; Itoh et al. 1999; Mattsson et al. 1999). 
There are thus profound differences in-between the transection and avulsion injuries 
with regards to regeneration capacity and re-growth of axons. 
 
 
Nerve model 
 
The type of nerve injured results in different end results, i.e. there is a difference in 
the vulnerability of the nerve. For example, the hypoglossal nerve seem to withstand 
axotomies better, as the level of motor neuron loss is less, as compared to the vagal 
and facial nerve when subjected to identical injuries (Aldskogius et al. 1984; 
Mattsson et al. 1999; Toyoda et al. 2006).  
 
 
Species and strain 
 
Not only species but also strain-dependant influences by differences in for example 
the immune and inflammatory changes after injury exist and have to be considered 
when evaluating and comparing results (Popovich et al. 1997; Sroga et al. 2003). 
Thus variations in genetic factors between the same species but different strains can 
influence outcome. In rats these strain differences are also observed after ventral root 
avulsion (Swanberg et al. 2006; Piehl et al. 2007).  
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Gender and age   
 
The age of the animal is strongly influencing the level of motor neuron cell loss and 
for example it is shown that most of the hypoglossal motor neurons survive in adult 
animals after a transection injury, while such an axotomy during development and 
early in postnatal life instead leads to massive depletion of motor neurons (Snider and 
Thanedar 1989; Fukuyama et al. 2006).   
There are also significant differences reported in male and female adult rats in the 
hypoglossal and facial nuclei, where females were shown to have a twofold greater 
neuronal cell loss after axotomies (Yu 1988). Furthermore, depletion of sex hormones 
in male animals elevates cell loss while administration of testosterone to females after 
injury reduces neuronal loss (Yu 1988; Yu 1989).      
 
 
3.3 Transmission vs. Growth  
 
An axotomy leads to a genetic switch from a transmitting to a survival mode as genes 
and proteins related to survival and regeneration are up-regulated (Carlstedt 2011). 
Alterations in genes related to e.g. growth factors and cytokines, signal- and receptor 
pathways, neurotransmitter receptors, transcription factors and cell cycle regulation 
are found  (Yang et al. 2006; Carlstedt 2011). There are differences between 
peripheral injuries and avulsion of motor nerves where an avulsion leads to up-
regulation of genes such as nitric oxide synthase (NOS), p53, Bax, Fas ligand, 
ANX3/5, TS, ALR and caspase which are associated with apoptosis and DNA 
damage (Piehl et al. 1998; Martin et al. 2005; Yang et al. 2006; Chu and Wu 2009). 
These responses also include down-regulation of N-methyl D-aspartate (NMDA) in 
order to protect the neuron from excitotoxic cell death (Piehl et al. 1995). 
Furthermore, there are other factors in the microenvironment stimulating regeneration 
following avulsion injury and such an axotomy induces changes not only within the 
neural and glial cellular compartments in the CNS, but also in the extracellular 
environment in favour for regeneration e.g. cleavage of the growth factor peptide 
precursors plasminogen activator and matrix-metalloproteinases (Hu et al. 2002). In 
addition, heat shock protein 27 (hsp27) and several trophic factors and their receptors 
are up-regulated following the injury (Hammarberg et al. 2000; He et al. 2003; Chu 
and Wu 2009).  
Several of these gene and protein expression alterations are not observed after a 
peripheral nerve axotomy such as a nerve transection. Here, instead, the machinery 
sets to only promote survival and regeneration as the motor neurons up-regulate 
expression of genes that are found to promote neurite outgrowth, axonal regeneration 
and motor neuron survival such as the low affinity nerve growth factor receptor (p75), 
alpha calcitonin gene-related peptide (CGRP), the insulin growth factor receptor II 
(IGFRII), IGF binding protein 6 (IGFBP-6), fibroblast growth factor 10 (FGF 10) and 
the G-protein-coupled receptor Galanin receptor 2 (Piehl et al. 1998; Yang et al. 
2006; Chu and Wu 2009).  
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The importance of growth- or neurotrophic factors cannot be underestimated in the 
promotion of survival and regeneration of injured motor neurons. Several families are 
described to act on motor neurons e.g. the Neurotrophins, the Neuropoietic family, 
Transforming Growth Factor Beta (TGF-β) superfamily, IGF, FGF, Hepatocyte 
Growth Factor (HGF), Vascular Endothelial Growth Factor (VEGF), the Serpin 
superfamily and the Midkine family (Chu and Wu 2009).  
The growth factors above have all been found to affect motor neurons during 
development as well as after injury, however, some of them are found to be of greater 
importance with regards to the survival and regeneration of the motor neuron after 
injury. For example, the VEGF family of proteins and their receptors have been 
shown not only to be an important factor in angiogenesis, but are also found to 
promote axonal outgrowth (Sondell et al. 2000). After axotomy VEGF is found to be 
expressed in axotomized motor neurons providing neurotrophic support paralleled by 
an increase in neuronal survival (Skold et al. 2000; Skold et al. 2004; Pereira Lopes et 
al. 2011). 
Both brain-derived neurotrophic factor (BDNF) from the neurotrophin family and 
glial cell line-derived neurotrophic factor (GDNF) from the TGF-β family have been 
found to prevent motor neuron cell loss after ventral root avulsions (Novikov et al. 
1995; Novikov et al. 1997; Wu et al. 2003; Yang et al. 2006). BDNF has been found 
to up-regulate several genes associated with neuronal survival and regeneration, and 
to down-regulate genes involved in apoptosis that are up-regulated after avulsion. 
 
 
3.4 Regeneration and Microsurgical Repair  
 
 
Peripheral nerve injury 
 
In the clinical setting, repair of peripheral nerve injuries include microsurgical 
techniques such as end-to-end repair with or without tissue adhesives and the use of 
autografts. Promising experimental techniques include for example synthetic adhesives 
and Schwann cell containing devices (Osmond 1999; Dvali and Mackinnon 2003; 
Landegren et al. 2011). In addition, also pharmacological treatment with the calcium 
flow inhibitor nimodipine has been suggested to promote neuronal survival and 
regeneration with improved functional outcome (Mattsson et al. 2001; Strauss et al. 
2006; Hydman et al. 2009). In addition, the role of physiotherapy in patients suffering 
from peripheral nerve injury should not be underestimated, as well as the clinical 
problems related to sensory side of these lesions including pain and dysesthesia. As 
important as these areas are, further elaboration is beyond the scope of this thesis. 
 
 
Avulsion injury 
 
Proximal axon disruptions caused by nerve avulsion induce massive motor neuronal 
cell loss, and requires axonal regeneration across the CNS-PNS border. Thus the 
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threshold for successful regeneration is far more complex here and involves partial 
growth through a short distance in the CNS. This involves surpassing myelin associated 
proteins and the glial scar, which is believed to have importance in sealing off the 
lesion from the intact tissue in the CNS (Fehlings and Hawryluk 2010). This scar is 
considered to be formed at least to some part by reactive astrocytes, but also from 
pericytes (Goritz et al. 2011).  
Thus, there is a structural barrier for axonal growth and regeneration after avulsion with 
axonal lesions in the CNS, but also a biochemical barrier from growth repellant 
components such as the Nogo protein, chondroitin sulphate proteoglycans (CSPGs), 
myelin-associated growth protein (MAG) and oligodendrocyte-myelin glycoprotein 
(OMgp) which act inhibitory by interfering with the regulation of axonal growth by 
inducing growth cone collapse, inhibit neurite growth and contribute to apoptosis 
(Busch and Silver 2007; Cao et al. 2010). 
However, both reimplantation and implantation of a peripheral graft after cervical and 
lumbar ventral root avulsion promotes the survival of motor neurons and results in 
axonal regeneration in the CNS across the CNS-PNS transitional zone and into the 
nerve root or nerve graft, overcoming the non-permissive environment of the CNS.  
(Carlstedt et al. 1989; Carlstedt et al. 1993; Wu et al. 1994; Cullheim et al. 1999; 
Hoang et al. 2006; Pinter et al. 2010).  
As previously discussed motor neuron survival and regeneration after injury is crucially 
dependant on support from the periphery, partly provided by proliferating Schwann 
cells, which by provision of both neurotrophic and neurotropic support contribute to the 
rescuing of motor neurons and allows for reconnection with the peripheral circuitry.  
Interestingly, it appears that Schwann cells express different motor and sensory 
phenotypes which support regeneration that is characterized by the phenotype, in such a 
way that a motor nerve graft is more favorable for motor neuron survival and 
regeneration than a sensory nerve graft (Hoke et al. 2006; Chu et al. 2008).  
Furthermore, a ventral root avulsion injury induces also intramedullary degeneration of 
sensory afferent axons and neuropathic pain, on which root reimplantation also seem to 
have beneficial effects (Bigbee et al. 2007; Bigbee et al. 2008).  
The severe avulsion injuries are most often seen in man after brachial plexus injuries 
and complicated deliveries resulting in devastating functional impairments, and often 
involves avulsion not only of one but in a majority of cases multiple nerves and roots 
(Narakas 1985; Havton and Carlstedt 2009). However, experimental findings show that 
the beneficial effects after a root reimplantation is not confined to the one level of 
implantation, but effects are also observed on adjacent levels although it appears that 
the axotomized neuron closest to the implantation site has the highest probability of 
axonal outgrowth into the implanted root (Hoang and Havton 2006).  
 
 
4 THE HYPOGLOSSAL NERVE MODEL   
 
The hypoglossal nerve, the XIIth cranial nerve supplies extrinsic and intrinsic muscles 
of the tongue, except for the palatoglossus muscle. The nerve plays a critical role in 
eating, swallowing and talking. An injury to the hypoglossal nerve presents with palsy 
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and atrophy of the ipsilateral muscles in the tongue. Although injuries of this nerve are 
rare they can include brainstem lesions e.g. after trauma or stroke, more peripheral 
injuries can be the result after trauma to the neck, hypoglossal nerve schwannomas, 
head- and neck surgery as well as after internal carotid artery dissections (Mathiesen et 
al. 2009; Jung et al. 2010; Oyama et al. 2012; Santis et al. 2012).  
Although considered a motor nerve, the hypoglossal nucleus is also found to have 
interneurons and projections from 5- Hydroxyltryptamine (5-HT) neurons in the caudal 
raphé nuclei, and dysfunction within this system is found to be involved in the sudden 
infant death syndrome (SIDS) (Kinney et al. 2009).  
 
The hypoglossal nucleus in the brainstem is an upward prolongation of the base of the 
anterior column of gray substance of the medulla spinalis where sections of the upper 
part of the nucleus, the hypoglossal trigone, protrudes slightly into the fourth 
ventricle and the lower part of the nucleus extends downward into the closed part of 
the medulla oblongata where it lies in immediate proximity to the central canal (Gray 
2008). Thus it is close to the ependymal region and the NPCs within this niche.   
Furthermore, from an experimental point of view the two hypoglossal nuclei in the 
brainstem are well defined but still close together on each side of the central canal, 
making it relatively easy to evaluate morphological changes in the same section from 
the brainstem having the experimental hypoglossal nucleus in the direct vicinity to the 
intact control side. The nuclei are also surgically accessible for e.g. microinjections at 
the floor of the fourth ventricle via a suboccipital, posterior fossa, midline approach, 
i.e. ideal for being hosts for cell transplantations with minor tissue trauma. 
In addition to this, the hypoglossal nerve injury can be considered equivalent to a 
ventral nerve or root injury.  
 
 
5 TRANSPLANTATIONS  
 
In the clinical setting transplantation of human fetal dopaminergic mesencephalic fetal 
tissue to patients with Parkinson’s disease was amongst the first where neural 
progenitors were grafted to the nervous system, and found to have beneficial effects 
with substantial clinical improvement in some of the patients (Bjorklund et al. 2003).  
Since the first of these transplantations in 1987 many reports are found on cell-based 
experimental transplantations to the CNS in injury and disease, not only in rodents, 
non-human primates but also from several clinical trials on patients (De Feo et al. 
2012).  
The absolute majority of these have been on spinal cord injuries, degenerative or 
immune-mediated neurological disorders, or experimental analogues, such as 
Parkinson´s and Huntington´s disease, amyotrophic lateral sclerosis (ALS) and MS 
(Pluchino et al. 2003; Xu et al. 2006; Parr et al. 2007; De Feo et al. 2012; Lu et al. 
2012; Riley et al. 2012).  
The beneficial effects of transplantations are considered to be of two major principles, 
first by direct cell replacement of dysfunctional or lost cells but also by a  
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neuroprotective, or so called bystander effect, e.g. by the production of growth and/or 
immunomodulating factors (De Feo et al. 2012; Reekmans et al. 2012). 
However, grafting of cells to the adult CNS comes with several considerations. A major 
concern is obviously from where to obtain and harvest the cells to be transplanted and 
both embryonal, fetal and adult NPCs have been used in allografting and xenografting 
experiments (Cummings et al. 2005; Parr et al. 2007; De Feo et al. 2012; Lu et al. 
2012).  
Embryonal or fetal neural progenitors might be preferential due to better proliferation 
and differentiation abilities when compared to adult cells, but raises some questions and 
potential limitations. These include all so important ethical and logistical considerations 
as well as the risk of infiltrative tumor formation the more primitive, or truly stem cell 
like, the NPC used is (Brederlau et al. 2006). 
With allo- and xenografting follows the risk of graft rejection and the concept of 
regarding the CNS as immune privileged is nowadays questioned, and does definitely 
not apply to when there is injury or disease affecting the CNS. As discussed previously, 
microglia are involved in the production of pro-inflammatory cytokines and have the 
potential to acquire phagoctyic and antigen presenting abilities thus, for example, 
allowing immune cells to recognize epitopes of non-self tissue (Streit et al. 1989; 
Svensson et al. 1995; Hoftberger et al. 2004; Ekdahl 2012).  
NPCs have been found to express MHC class molecules and thus it might be necessary 
to supply the host with immunosuppressant medication targeting the T cells, e.g. 
cyclosporine A (Rezzani 2006; Laguna Goya et al. 2011). Hence, giving rise to risks of 
graft rejection and/or negative effects from additional pharmacological treatment.  
 
To overcome some of the issues stressed above, for example availability and ethical 
considerations, mesenchymal stem cells have been used in experiments on nervous 
system repair, and although not found to produce the significant number of neurons as 
once suggested some beneficial effects have been shown (Parr et al. 2007; Barnabe-
Heider and Frisen 2008; Parr et al. 2008).  
One promising, and by the Nobel Committee at the Karolinska Institutet appreciated, 
strategy to be used in grafting for neural repair, is to reprogram fully differentiated 
somatic cells to become cells that possess pluripotency, i.e. to induce pluripotent cells 
(Takahashi and Yamanaka 2006; Takahashi et al. 2007).  
For apparent reasons a thesis on the topic of stem/progenitor cells and neural repair 
cannot be presented in December 2012 without elaborating on induced pluripotent stem 
cells (iPS cells) (Gurdon 1962; Takahashi and Yamanaka 2006).  
With this strategy the use of embryonic and fetal tissue is not necessary, as for example 
a somatic cell such as a fibroblast can be induced to acquire stem or progenitor cell 
characterisistics, giving rise also to neural progenitors to be used for example in 
experimental research on neural repair and for grafting. Furthermore, 
immunosuppression is avoided since basically any kind of  patient-specific NPC can be 
generated, which in turn can be differentiated into region-specific neuronal cells as 
needed (Wu and Hochedlinger 2011; Sommer and Mostoslavsky 2012).  
It has also been shown that iPS cells can be generated from adult neural 
stem/progenitor cells (Kim et al. 2008).  
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The induction, or reprogramming, in the 2006 Yamanaka experiment included four key 
pluripotency genes of which one of them was the Sox2 gene, the other three were Oct-
3/4, c-Myc and Klf4 (Takahashi and Yamanaka 2006).  
 
With regards to transplantation regimes to the CNS after motor nerve injuries the 
reports are few, and when it comes to the use of adult NPCs I have not been able to find 
any papers reporting on this. In two reports a beneficial effect on motor neuron 
numbers, attributive to a neuroprotective effect by growth factors, have been found 
(Rodrigues Hell et al. 2009; Su et al. 2009). However in these reports embryonic NPCs 
and mesenchymal stem cells, respectively, were used as grafts.  
In this study we transplant adult NPCs after nerve axotomies in order to evaluate adult 
cells in a repair strategy, eventually in a model of autografting. By this we hope to 
reduce many of the concerns with strategies using embryonic, fetal and non-self tissue 
such as ethical and availability concerns, infiltrative tumor formation risks, graft 
rejection problems and potential detrimental side effects associated with cell harvesting.  
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AIMS OF THE STUDY 
 
 
 
 
 
 
 
 
 
I. Investigate whether hypoglossal nerve transection or avulsion injury that generates 
low and high neuronal cell death respectively, induces neuro-/gliogenesis from 
progenitor cells in the ependymal region of the central canal and 4th
 
 ventricle. 
 
II. Evaluate survival, differentiation and integration of grafted NPCs in a new animal 
model. 
 
 
III. Determine if survival and integrative capacity of transplanted NPCs was correlated 
to the extent of the injury. 
 
 
IV. Investigate the potential presence of NPCs in the filum terminale. 
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MATERIAL AND METHODS 
 
 
 
 
 
 
 
 
 
1 ANIMAL EXPERIMENTS 
 
All animal experiments were approved by the local ethical committee on animal 
research and animal care was in accordance with institutional guidelines. Animals were 
housed in an environmentally controlled room temperature at 21 ± 1°C with a 12 h:12 h 
light/dark cycle, with food and water administered ad libitum.  
Adult animals were used in all experiments. For experiments in Paper I female 
Sprague-Dawley rats weighing 220-250 g were used. For the experiments in Papers II 
and III Lewis male rats, 300-450 g, were used and in Paper IV male Sprague-Dawley 
rats weighing 400-500 g.  
All animals were anesthetized using intraperitoneal injection of medetomidine 
(Domitor® vet. 1mg/ml, OrionPharma, Espoo, Finland) 0.5mg/kg and ketamine 
(Ketalar® 50mg/ml, Pfizer Sollentuna, Sweden) 75mg/kg.  
 
 
1.1 Labeling of Cells in The Ependymal layer (Paper I) 
 
The ependymal cell layer was labeled using stereotaxic injection of 20µl 0.1% DiI 
(1,1´-dioctadecyl-6,6´-di(4-sulfophenyl)-3,3,3´,3´-tetramethylindocarbocyanin) 
(Molecular Probes/Invitrogen, Eugene, OR, USA) in dimethyl sulfoxide (DMSO) in 
the lateral ventricle on the right side (0.9 mm posterior and 1.4 mm lateral of bregma, 
and 3.6 mm below the dura mater) (Paxinos and Watson 1986). DiI is a lipophilic dye 
and was used in the experiments in order to trace cells. Ten days after DiI 
administration animals were subjected to hypoglossal nerve (n.XII) injury, see below.  
 
 
1.2 BrdU Injections (Paper I) 
 
In order to assess proliferating cells we used the proliferation marker 5-Bromo-2´-
deoxyuridine (BrdU) (Sigma-Aldrich Sweden, Stockholm, Sweden). BrdU is a 
thymidine analogue that is incorporated into the DNA of dividing cells during the S-
phase of the cell cycle. The expression can then be detected by the use of an antibody 
directed against the incorporated analogue. In our experiments 100mg/kg in NaCl 
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9mg/ml was administered subcutaneously once daily for a maximum of ten days, 
commencing at the day of injury, see below. 
 
 
1.3 Hypoglossal Nerve Injury (Papers I, II and III) 
 
Two types of axotomies were performed during the experiments that laid the 
foundation for this thesis; transection injury and avulsion injury of the n.XII on one (the 
right) side. During transection the whole nerve was cut, leaving two approximate ends, 
and by avulsion is meant the shear tearing of the nerve from its origin in the brainstem. 
In both types of axotomies the nerve injury was made at the level where the n.XII 
passes the external carotid artery on the right side.  
 
 
1.4 Cell Preparation (Papers II, III and IV) 
 
 
Subventricular zone tissue 
 
For the transplantation experiments subventricular zone (SVZ) neural progenitor cells 
(NPCs) were obtained from adult Lewis rats (RRRC Missouri University, Columbia, 
MO, USA (http://www.nrrrc.missouri.edu)), carrying an insertion of the enhanced 
green fluorescent protein (eGFP-transgene) under the Ubiquitin C promoter on 
chromosome 5. Genotyping was performed by following the genotyping protocol from 
RRRC-Missouri (http://www.nrrrc.missouri.edu). A REDExtract-N-AMP Tissue PCR 
Kit from sigma (cat# XNAT 100 reactions) was used to extract the DNA from the ear 
tip biopsy from each animal. Animals that were homozygous for the eGFP transgene 
were selected as donors, and eGFP non-carrier siblings were selected as the receivers of 
the transplant (see below). 
The rats were 7 to 8 weeks old at day of cell isolation. Cells were isolated in 
accordance to a protocol described by Johansson and co-workers (Johansson et al. 
1999). The cells were propagated for two passages in Dulbecco's modified Eagle's 
medium/F-12 (DMEM/F12) (Gibco, Life Technologies, NY, USA) containing B27 
supplement (Gibco), penicillin (100 U/ml) (Gibco), streptomycin 
For the in-vitro differentiation analysis of cell cultures spheres were split after two 
passages into single
(100µg/ml) (Gibco), 
epidermal growth factor (EGF) (20ng/ml) (Sigma-Aldrich) and basic fibroblast growth 
factor (bFGF) (10ng/ml) (R&D Systems Europe Ltd, Abingdon, UK). After the second 
passage, neurospheres were dissociated and cells were resuspended in a solution that 
contained 100,000 cells/5µl in DMEM/F12 medium enriched with EGF (20ng/ml) and 
bFGF (10ng/ml).  
 cell suspensions, seeded on poly-D-lysine-coated plates, and 
cultured in medium lacking mitogens but supplemented with 1% 
 
fetal calf serum 
(FCS). The cultures were differentiated for 7 days, and then fixed with 4% 
paraformaldehyde (PFA). 
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Filum terminale tissue 
 
Under the operating microscope laminectomies were performed, the conus medullaris 
identified and filum terminale was dissected in its whole length and extirpated in toto. 
Thereafter cells were cultured in the same way, and with the same protocol, as 
described above for the SVZ NPCs. Fixation procedures for cultures were also the 
same. 
 
 
1.5 Transplantations (Papers II and III) 
 
The non-carrier siblings i.e. wild-type (wt) animals to the eGFP transgenic (Tg) 
animals, described in section 1.4 above, were the recipients in the transplantation 
experiments.   
Nine days after n.XII injury the animals were reanesthetized and placed in a stereotaxic 
frame (Kopf®, David Kopf Instruments, Tujunga, CA, USA). During microsurgery the 
brainstem was exposed and the obex identified. A glass micropipette (Clark 
Electromedical Instruments, Reading, UK) was pulled to an aperture of 90µm, adapted 
and sealed onto a Hamilton syringe (Hamilton Company, Bonaduz, Switzerland) and 
connected to a Univentor 802 syringe pump (Univentor, Zejtun, Malta). At 
approximately 0.3 mm caudal and 0.1 mm lateral (right) to the obex 100,000 NPCs in 5 
µl culture medium DMEM/F12 enriched with mitogens as described above were 
injected into the right hypoglossal nucleus (nucl.XII). Cells were injected as single cells 
and the volume was administered at 2 µl/min. The glass micropipette was left in place 
for 5 min and then withdrawn. Some of the animals received 5 µl DMEM/F12 enriched 
with mitogens in the same proportions only, i.e. no NPCs were grafted to this group.  
All the animals received immunosuppressant therapy by injections of cyclosporine 10 
mg/kg (Sandimmun® 50mg/ml, Novartis, Täby, Sweden) subcutaneously once daily 
starting one day prior to transplantation of NPCs or cell medium only injections. After 
four weeks the cyclosporin was given three times/week.           
 
 
2 HUMAN MATERIAL  
 
The study on human material (Paper IV) was carried out in accordance with the 
Helsinki declaration, and the experimental procedures were approved by the Stockholm 
county ethical committee for human research. Tissue from patients was obtained from 
Karolinska University Hospital only and after informed consent by the patient or parent 
in accordance with the ethical approval. 
Filum terminale (FT) tissue was obtained from young and adult patients (ages 1-60 yrs) 
(n=21) between the years 2006-2011 (Table 1).  
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All patients underwent MRI scans to exclude tumors and were screened for the 
presence of infectious disease prior to surgery. The tissue was immediately stored in 
L15 medium (4°C) in the operating theatre and immediately transported to the 
laboratory. Connective tissue was peeled off and the FT was mechanically dissociated 
with scalpels and scissors, and placed in a dissociation medium consisting of 200 U/ml 
DNAse (Sigma-Aldrich) and 0,025% trypsin (Invitrogen) or 10 U/ml papain 
(Worthington, Lakewood, NJ, USA) in a 37°C water bath for 30 min. Tissue was 
triturated three times every 5 min, and further incubated. To stop the enzymatic 
reaction, 10 mg/ml BSA (Sigma-Aldrich) and 10 mg/ml ovomucoid (Worthington) 
were mixed with L15, added and mixed with the dissociation medium. Cells were 
collected by centrifugation at 220g for 5 min. To further enrich for progenitor cells, 0.9 
M sucrose in Hanks’ Balanced Salt Solution (HBSS) (Invitrogen) was added to the 
tissue solution followed by centrifugation at 750g for 10 min and washing with L15 
medium. The cell pellet was resuspended to allow for single cell cultures in 5 or 10 cm 
diameter petri dishes in neurosphere medium composed of DMEM/F12 (Invitrogen), 
HEPES (Gibco), B27 supplement (Gibco) and Penicillin-Streptomycin (Invitrogen). 
The following growth factors were added; 20 ng/ml recombinant human epidermal 
growths factor (EGF) (R&D Systems) or mouse EGF (BD Biosciences, Franklin Lakes, 
NJ, USA) and 20 ng/ml recombinant human basic fibroblast growth factor (bFGF) 
(R&D Systems). After the first passage, 10 ng/ml recombinant human leukemia 
inhibitory factor (LIF) (Chemicon/Millipore Sweden AB, Solna, Sweden) was added to 
the medium. The neurospheres were cultured until they reached a critical size which 
normally took seven weeks. Another set of cells were cultured in neurosphere medium 
with the addition of 20% BIT 9500 medium. BIT medium consists of BSA, Insulin 
(Sigma-Aldrich) and 20 ng/ml transferrin (Stem Cell Technologies, Grenoble, France). 
Platelet-derived growth factor-BB (PDGF-BB) (R&D systems) was added at 30 ng/ml. 
Cells were incubated for eight days and the medium was changed three times. Cells 
cultured with BIT 9500 medium were differentiated on gelatine-coated plates (Sigma-
Aldrich). In order to exclude contamination of the data by tumor forming cells, all 
tissue preparations were screened for the presence of the P53 gene. Cell cultures were 
fixed with 4% PFA. In order to evaluate the proliferation capacity of FT another set of 
culture was performed as previously described. After passage the neurospheres were 
pulsed with BrdU (Sigma-Aldrich) for 48h in the presence of EGF and bFGF. The 
spheres were placed on coated glasses before fixation in 4% PFA.  
 
 
Table 1. Age of donors, 
human filum terminale tissue.  
(From Arvidsson, Fagerlund et 
al PLoS ONE 6(11), 2011). 
 
 
Age group N 
1-5 8 
6-15 8 
>30 5 
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3 EXPERIMENTAL GROUPS 
 
 
3.1 Paper I 
 
A total number of 102 animals were used. 30 animals were subjected to transection 
injury and 60 to avulsion injury. Survival times were 2, 4, 7, 14 and 28 days after nerve 
injury (n=6 in the transection group and n=12 in the avulsion group at every time 
point). 12 animals were sham operated, i.e. skin incision and soft tissue dissection was 
performed as for the transected and avulsed animals, however no nerve injury was 
performed. All animals received DiI and BrdU. See Figure 1 for illustration of 
experimental setup. 
 
 
 
 
 
Figure 1. Experimental setup in Paper I. 
 
 
 
 
 
 
3.2 Paper II 
 
In this study a total of 104 animals were included of which 8 animals were uninjured 
controls, which constituted group I. The other three groups were II) injury only, i.e. the 
n.XII was avulsed, however without injections into the brainstem nucleus, III) injury 
and injection of cell medium (no cells) to the ipsilateral nucl.XII and IV) injury and 
transplantation of NPCs to the ipsilateral nucl.XII. Survival times for animals in groups 
II-IV were 2, 7 and 28 days and 3 months (n=8 in each group and survival time). 
All animals, also the controls, received immunosuppression. For a schematic 
illustration of the experimental setup for this paper see Figure 2. 
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Figure 2. Experimental setup in Paper II. 
 
 
 
3.3 Paper III 
 
50 animals were included. The control group (group I) (n=6) was composed of 
uninjured animals. In the other three groups a n.XII transection injury was performed 
and the groups were setup in a similar fashion as for Paper II, thus the second group 
included animals with nerve injury but without brainstem injections, group three 
received cell medium injections into the ipsilateral nucleus of the n.XII after nerve 
injury and the fourth group received NPCs injected into the ipsilateral nucl.XII after 
nerve transection. Survival times were 28 days and 3 months, n=6 in each group and 
survival time. In this study 8 animals with an avulsion injury followed by NPC grafting 
from Paper II were evaluated and included for comparison.  
 
 
3.4 Paper IV 
 
Human tissue 
 
Patients suffering from tethered cord underwent neurosurgical procedures in order to 
resolve the tethering of the FT. The total number of patients included in the study was 
21, both young and adult (ages 1-60 years). All patients underwent MRI scans prior to 
neurosurgery in order to exclude tumors and were also screened for the presence of 
infectious disease.  
  
Animal tissue 
 
A total number of seven animals were included.  
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4 TISSUE PROCESSING 
 
 
4.1 Animal Tissue (Papers I, II, III and IV) 
 
At sacrifice animals were reanesthetized and transcardial perfusion with body-
temperatured (37°C) saline followed by cold (4°C) 4% PFA in PBS performed. The 
brainstems (Papers I, II and III), the n.XII on the right side (Paper III), tongue 
(Paper III) and the FT (that was not to be prepared for cell culture, see section 1.4 
above) (Paper IV) were removed and post-fixed for 60-120 min in cold (4°C) 4% 
PFA in PBS followed by rinse in PBS and cryoprotected for 1 (FT) or 48 hours 
(brainstems, nerve and tongue) in 15-17 % sucrose (w/v) in PBS. The nucl.XII was 
serially cryosectioned (14µm) using a Leica CM3000 (Leica Microsystems, Kista, 
Sweden) cryostat. The tongue was cut into 14µm thick coronal sections and 
longitudinal cryostat sections (10µm) were made of the n.XII. The FT was 
cryosectioned in longitudinal and transverse (10µm thick) sections. Tissue was then 
mounted on SuperFrost® Plus microscope slides (Menzel-Gläser, Braunschweig, 
Germany).  
 
 
4.2 Human Tissue (Paper IV) 
 
For a detailed description of processing of the human material please refer to section 2 
in materials and methods above. Parts of the FT that was not to be prepared for cell 
culture was fixed in ice-cold 4% paraformaldehyde (PFA) for 24 hours, and 
cryoprotected in 17% sucrose (w/v) in phosphate buffer (PBS) before being imbedded 
in Cryomount (HistoLab, Gothenburg, Sweden). The FT was then longitudinally and/or 
coronally sectioned (10µm thick sections) and mounted as described in section 4.1 
above.  
 
 
5 IMMUNOHISTOCHEMISTRY 
 
Both indirect immunofluorescence and the avidin-biotin complex (ABC) technique 
were used. 
Cell culture sections (Papers II, III and IV) were blocked by incubation in PBS with 
5% goat serum and 0.1% saponin. All the cryostat sections (Papers I, II, III and IV) 
were first washed in PBS for 30 min before incubation for 60 min in PBS containing 
1% bovine serum albumin (BSA), 0.3% Triton-X or 0.1% saponin and 0.1% sodium 
azide. 
All of the primary antibodies used were diluted in these solutions. For staining of 
dividing cells, S-phase of cell cycle, sections were pretreated with 0.1 M NaOH for 2 
min followed by a rinse with PBS (pH 8.5) for 30 seconds and then incubated with 
antisera to single stranded DNA containing BrdU (Svensson and Aldskogius 1993). 
Both cell culture and cryostat sections were incubated with one or, for multiple 
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staining, two or more of the primary antibodies. For the primary antibodies used in 
this study please see Table 2. For negative controls the primary antibody was omitted. 
All of the sections were incubated with the primary antibody for 24 h at 4°C, rinsed in 
PBS and subsequently incubated with species-specific secondary antibodies diluted in 
PBS. See Table 3 for a list of secondary antibodies.  
Some of the sections were also counterstained with the nuclear markers 4´,6-
Diamidino-2-phenylindole (DAPI) (Invitrogen) (dilution 1:2000) or TO-PRO-3 
(Invitrogen) (1:10000). After another step of washing in PBS sections were mounted in 
Mowiol (Calbiochem, Merck Chemicals Ltd, Nottingham, UK). 
 
 
 
 
 
 
 
 
 
Table 2. Primary antibodies used in the study. 
 
 
 
 
 
 
 
Antibody Species & Type Dilution Source 
 
Bassoon 
BDNF 
BrdU 
ChAT 
Doublecortin 
ED1 
GFP 
GFAP 
GFAP 
GPx1 
Musashi 1 
Nestin 
NeuN 
O4 
OX42 
p53 
SDF-1α 
Sox2 
Synaptophysin 
VEGF 
Tubulin β-III isoform 
 
rabbit polyclonal  
rabbit polyclonal 
mouse monoclonal 
mouse monoclonal 
goat polyclonal 
mouse monoclonal 
rabbit polyclonal 
rabbit polyclonal 
mouse monoclonal 
goat polyclonal 
rabbit polyclonal 
mouse monoclonal 
mouse monoclonal 
mouse monoclonal 
mouse monoclonal 
rabbit polyclonal 
rabbit polyclonal 
rabbit polyclonal 
rabbit polyclonal 
rabbit polyclonal 
mouse monoclonal 
 
1:100 
1:1000 
acc. to supplier 
1:100 
1:500 
1:2000 
1:500 
1:1000 
1:1000 
1:50 
1:200 
1:100/1:200 
1:100 
1:50 
1:1600 
1:400 
1:50 
1:200 
1:100 
1:50 
1:100 
 
Abcam 
Chemicon/Millipore 
Amersham 
Abcam 
Santa Cruz Biotechn. 
Abd Serotec 
Chemicon/Millipore 
DAKO 
Chemicon/Millipore 
R&D Systems 
Chemicon/Millipore 
Chemicon/Millipore 
Chemicon/Millipore 
Chemicon/Millipore 
Harlan SeraLab 
Santa Cruz Biotechn. 
Santa Cruz Biotechn. 
Chemicon/Millipore 
Abcam 
R&D Systems 
Chemicon/Millipore 
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For the ABC-technique sections were incubated with biotinylated secondary 
antibodies (Vector Laboratories, Vector Laboratories Ltd, Peterborough, England) 
(1:200) for 1 h at room temperature, rinsed in PBS and incubated with ABC 
(Vectastain ABC Kit, Vector Laboratories) for 1 h. After another step of rinsing in 
PBS followed by TRIS-hydrogen chloride buffer (0.1 M, pH 7.45) immunoreactivity 
was revealed by incubation in 3, 3´-diaminobenzidine (DAB) by using the DAB 
Substrate Kit for Peroxidase (Vector Laboratories) for 2-10 min. Sections were rinsed 
in TRIS and dehydrated through a series of graded ethanol’s to xylene and mounted 
in a non-aqueous DPX-medium. 
To asses motor neuron profiles in the nucl.XII (Papers I, II and III) some of the 
sections were stained with cresyl violet and dehydrated in a series of ethanol and 
xylene prior to mounting in a non-aqueous medium (Pertex®, HistoLab) before 
mounting.  
 
 
Table 3. Secondary antibodies used in the study. 
Secondary Antibody Dilution Source 
 
Alexa 488 donkey anti-mouse 
Alexa 488 donkey anti-rabbit 
Alexa 488 donkey anti-goat 
Alexa 594 donkey anti-mouse 
Alexa 633 goat anti-mouse 
FITC goat ant-rabbit 
Cy3 goat anti-mouse 
Cy3 donkey anti-mouse 
Cy3 goat anti-rabbit 
Cy3 donkey anti-rabbit 
Cy5 goat anti-rabbit 
 
1:500 
1:500 
1:500 
1:500 
1:500 
1:200 
1:500/1:1000 
1:500/1:1000 
1:500/1:1000 
1:500/1:1000 
1:200 
 
Invitrogen /Molecular Probes 
Invitrogen /Molecular Probes 
Invitrogen /Molecular Probes 
Invitrogen/Molecular Probes 
Invitrogen/Molecular Probes 
Jackson ImmunoResearch 
Jackson ImmunoResearch 
Jackson ImmunoResearch 
Jackson ImmunoResearch 
Jackson ImmunoResearch 
Jackson ImmunoResearch 
 
 
 
 
 
6 MICROSCOPY AND QUANTIFICATION 
 
 
6.1 Confocal Microscopy (Papers I, II, III and IV) 
 
Immunolabeling experiments were analyzed by confocal laser-scanning microscopy 
for visualization of double and triple immunolabeled cells. A Leica TCS SP II system 
(Leica Microsystems, Heidelberg, Germany) was used and argon-krypton and 
helium-neon lasers were used to excite the fluorochromes at 488, 543, 594 and 633 
nm. Fluorescence was detected with 490-520, 560-630, 610-650 and 640-750 band 
pass filters, respectively. Images were taken using a 20x (numeric aperture (N/A) 0.7) 
and 63x (N/A 1.40) objective.    
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6.2 Widefield Microscopy (Papers I, II, III and IV) 
 
Fluorescence was also detected and antibodies assessed by the use of a widefield 
Leica DM 4000 B microscope (Leica Microsystems) on which also the light 
microscopy was performed.  
 
 
6.3 Cell Counting (Papers I, II and III) 
 
To carry out a semiquantitative determination of the number of motor neurons 
(Papers I, II and III) 8-10 sections, stained with cresyl violet, from each brainstem of 
the nucl.XII at the same level for each experimental and control group were analyzed. 
For this, light microscopy with a 40x objective was used, and neuronal profiles that 
had a clear nucleus and nucleolus were included at every 168µm throughout the 
hypoglossal nucleus. The method of Abercrombie was used to correct for volume 
changes of individual neuronal profiles (Abercrombie 1946; Mattsson et al. 1999).  
For evaluation of the proliferative response in the ependymal layer (Paper I), sections 
at every 224µm of the nucl.XII were obtained (approximately 8 sections from each 
brainstem), and cells that co-localized BrdU and DiI in the ependymal layer were 
included. The numbers of transplanted neural progenitor cells were estimated by 
counting eGFP-expressing cells in 8 sections from animals receiving grafts, and 
differentiation was assessed in 2-4 sections for each cell marker (Papers II and III). 
The number of eGFP in the sections was expressed as a percent cell survival of the 
total number of viable cells injected. This number, i.e. an estimate of viable cells 
injected, was assessed by the use of Trypan Blue. 
 
 
7 STATISTICAL ANALYSIS 
 
Data are presented as mean ± SD. Measurements were followed by statistical analysis 
by using unpaired two-tailed Student´s t-test, for multiple group comparison one-way 
analysis of variance followed by Tukey´s post test was implied (Papers I, II, III and IV) 
(GraphPad Prism® 5.0, GraphPad Software Inc., La Jolla, CA, USA). P < 0.05 was 
defined as statistical significance.  
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SUMMARY OF RESULTS 
 
 
 
 
 
 
 
 
 
This is, as stated in the heading, a summary of the results found in the experiments 
that laid the foundation for this thesis. For a more detailed presentation, please refer 
to each individual paper.  
 
 
1 MOTOR NEURON CELL LOSS 
 
The crystal violet staining of motor neuron profiles in the hypoglossal nucleus 
(nucl.XII) revealed more pronounced cell loss after hypoglossal nerve (n.XII) 
avulsion injury, than after nerve transection. The differences were observed in both 
Sprague-Dawley (SD) and wild-type (wt) Lewis rats. In Paper I there was a 
significant decrease in motor neuron profiles in the nucl.XII at 28 days after avulsion 
when compared to controls. Approximately 43% of the cells were lost, as compared 
to the transection injury group were we could not observe any significant differences 
at 28 days when compared to the controls. When examining the wt Lewis animals 
these differences prevailed (Papers II and III) as we found an almost 60% loss of 
motor neuronal profiles at 28 days after avulsion injury, and as much as an almost 
75% loss at 3 months. After transecting the n.XII, only about 10% on average at 28 
days and 15% after 3 months were lost. 
 
 
2 INFLAMMATORY AND GLIA CELL RESPONSE  
 
There are many ways to characterize the levels of inflammation. In this study we 
assessed this by investigating the levels of microglia (OX42), macrophages (ED1) 
and the levels of one of the more important antioxidant enzymes, glutathione 
peroxidase 1 (GPx1). 
There was a strong and intense activation of microglial cells after both transection 
and avulsion of the n.XII which reached a maximum at 7 days after injury (Paper I), 
however no difference in the levels of OX42 could be detected between the two 
groups. On the other hand we observed differences in the levels of ED1-positive cells 
(Paper I) as well as GPx1-immunoreactivity (Paper III). After avulsion injury ED1 
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was found in the nucl.XII ipsilateral to nerve injury from day 7 post injury and 
onward, while transected animals displayed very few ED1 labeled cells which were 
not found before 28 days after the injury. With regards to GPx1 our results showed 
higher expressions of GPx1 in transplanted NPCs in the avulsion model, when 
compared to grafting after transection. Also the expression of the GPx1 protein was 
more intense in the surrounding area adjacent to where the transplanted cells where 
localized, i.e. in the nucl.XII. This was in contrast to the transection model, where the 
expression of GPx1 was restricted to the cells.  
This would indicate that in addition to the differences in motor neuron profiles after 
the two types of injury there is also a difference in the levels of inflammation, 
although we were not able to detect any significant differences in microglial levels.   
The astrocytic response (assessed by GFAP expression) was profound after both 
transection and avulsion and reached the highest levels at 14 days after injury after 
which a decline was seen (Paper I).   
 
 
3 ENDOGENOUS PROGENITOR CELL ACTIVATION 
 
All of the results in this section were obtained from Paper I. 
 
 
In the immediate vicinity to the nucl.XII Sox2-positive cells were found in the 
ependymal region in the central canal and fourth ventricle in the brainstem. The 
expression was abundant. Quantification of Sox2 expressing NPCs did not reveal any 
differences between transection and avulsion injury. However, Sox2-positive cells 
were also found subependymal to the ependymal layer and there was a dorsal-ventral 
polarization of the Sox2 cells with significant more cells in the middle and dorsal 
parts of the central canal region, as compared to the ventral part. 
When we investigated the proliferation of these cells after avulsion injury BrdU-
immunoreactivity was confined almost exclusively to the dorsal parts and increased 
from 4 days, progressed at 7 days post injury after which a decline was observed at 
later survival times. The increase was significant when compared to control animals. 
This increase in proliferation was not seen after nerve transection.  
After avulsion, but not transection, Nestin was expressed in the ependymal layer at 7 
days after injury. In avulsed animals DiI-labeled cells were detected in the nucl.XII 
ipsilateral to nerve injury, indicating migration from the ependymal layer. The 
migrating DiI-positive cells expressed GFAP and some of them also showed 
immunoreactivity for BrdU. We could not detect cells expressing neuron or 
oligodendroglia markers. No migrating cells were observed in the contralateral, 
uninjured, nucl.XII.  
In the avulsed animals we were able to find the chemotactic cytokine SDF-1α in the, 
to the injury, ipsilateral nucl.XII. SDF-1α was expressed in GFAP-positive cells and 
observed from 4 days after injury with a gradual increase at later survival times. 
Again, this was not found in controls or in transected animals. 
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Thus our findings indicated proliferation, migration and differentiation of ependymal 
region NPCs after avulsion injury, but not transection, showing that there is quite a 
difference in endogenous NPC activation between the two models of axotomy. 
However, in these experiments neuronal differentiation failed.   
 
 
4 TRANSPLANTATIONS 
 
All of the results in this section were obtained from Papers II and III. 
 
 
4.1 Characterization of Subventricular Zone Progenitor Cells   
 
In order to assess stemness and differentiation potential of the cells aimed for 
transplantation, we categorized the cultured cells that were harvested from the SVZ of 
the eGFP transgenic (Tg) Lewis animals. Before differentiation approximately 90% 
of the cells expressed Sox2 indicating they were NPCs. After differentiation for 7 
days in-vitro the cells possessed the ability to differentiate into neurons (2-4%), 
oligodendrocytes (35-40%) and astrocytes (57-61%).  
We concluded that cells from the SVZ of adult Lewis eGFP Tg animals had the same 
abilities as has been established for cells from the SVZ in wild-type animals.  
 
 
4.2 Viability of Cells Prior to Transplantation  
 
In order to assess the viability of cells aimed for grafting we used trypan blue, which 
traverses the cell membrane in a dead cell but is not absorbed in a viable cell. This 
showed that 85-90% of the cells were viable before transplantation. 
 
 
4.3 Survival, Differentiation and Integration of Cells 
 
Transplanted cells were detected by their eGFP expression. The identity of the cells 
as grafted NPCs was also confirmed with the use of the non-fluorescent ABC-
technique where an antibody directed against GFP was applied. The majority of cells 
were found in the nucl.XII ipsilateral to nerve injury, although cells were also seen in 
the trajectory channel.  
At the early time points, 2 and 7 days (Paper II), grafted cells appeared small and 
round, without morphological differentiation and were not expressing phenotypic 
markers for neurons, oligodendrocytes or astrocytes. When assessed at 3 months we 
estimated that as many as 10% of transplanted cells were present, however the 
number was highly variable between subjects. Numerous of the grafted cells in the 
nucleus of the avulsed n.XII displayed morphology characterisistics for neurons, 
including long extensions indicating axons and dendrites. Some of these cells were 
found to express Tuj-1, we estimated this number to 5.1% of the total number of 
transplanted eGFP NPCs, and some of them were found to also express NeuN. 
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However, the majority of grafted cells, more than 60%, were co-labeled with GFAP 
indicating differentiation towards the astrocytic lineage. Although present, few of the 
transplanted cells (<1%) expressed oligodendrocyte markers, and these cells tended to 
maintain a round, immature, appearance although some of them displayed a 
spreading, plane morphology. These findings were in contrast to the results we 
obtained from transected animals. In these animals transplanted eGFP cells appeared 
small and round with an immature morphology also at 3 months. The cells did not 
display immunoreactivity for neurons or oligodendrocytes and the number of GFAP-
positive eGFP cells was much less, only about 15%. The total estimated number of 
eGFP cells at 3 months in the hypoglossal nucleus as compared to the total number of 
transplanted cells also differed between these two injury groups; in the avulsion group 
10% of cells were detectable as compared to less than 2% in the transection injury 
group. Another difference between the groups was that 25-30% of the eGFP cells still 
expressed Sox2 in transected animals, indicating that these cells were still in a neural 
progenitor cell state. Sox2 was not found in eGFP cells in the avulsed animals.  
In order to determine integration of grafts in the nucl.XII we applied a protocol for 
labeling with markers for synaptic connectivity. In this study synaptophysin and 
bassoon. These two markers were found to be present around the transplanted cells 
and along the dendrite-like extensions (synaptophysin) and also around the grafted 
cell bodies (bassoon) in the nucl.XII after avulsion injury but not transection. Thus 
we interpreted this to indicate that eGFP NPCs were integrated after transplantation to 
animals with nerve avulsion injury, but not transection. 
 
 
4.4 Effects on Motor Neuron Survival  
 
As many motor neurons were lost in the nucl.XII ipsilateral to nerve avulsion we 
assessed whether the transplanted NPCs could increase the number of motor neurons, 
either by differentiation into motor neurons, thus replacing the ones lost, or by 
reducing the loss of motor neurons. This was also compared between the two 
axotomy models. 
In none of the papers were we able to detect differentiation into motor neurons as we 
were not able to find ChAT-immunoreactivity in eGFP NPCs, neither could we detect 
cells with motor neuron morphology that were expressing eGFP. However, there was 
a significant increase in number of motor neuron profiles in the nucl.XII after nerve 
avulsion in animals receiving NPCs. After NPC transplantation in these animals 55% 
of motor neurons were present at 28 days and 46% at 3 months and displayed 
morphology as of the motor neuron profiles in controls. The numbers were significant 
when compared to avulsed animals without grafting where only 43% and 24% of 
motor neuron profiles were present at 28 days and 3 months respectively and, 
notably, also to animals receiving injections of cell medium only to the nucl.XII. 
Transplanted NPCs thus were able to reduce motor neuron cell loss after avulsion 
injury, and were found to express the neurotrophic factor vascular endothelial growth 
factor (VEGF) after grafting to the nucl.XII, as well as in-vitro. In addition, we found 
intense expression of the antioxidant GPx1 (see also section 2 above) in the eGFP 
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NPCs in the avulsed group. We suggest that this up-regulation of GPx1 is crucial for 
their, and also the motor neurons, own survival in a microenvironment with local 
accumulation of inflammatory compounds and free radicals. 
GPx1 expression was also found after grafting of NPCs to transected animals, 
however not as intense.  
When compared to the results obtained after avulsion injury of the n.XII, the number 
of motor neurons in the nucl.XII was not influenced by the graft after transection of 
the nerve.  
As a transection injury would provide better conditions for axon regeneration we 
investigated whether the transplanted cells had the ability to form regenerating axonal 
projections. We extirpated and examined the n.XII from its exit point at the brainstem 
to its projection into the tongue but were not able to detect green fluorescent axonal 
structures within the nerve, neither were we able to detect signs of eGFP in the 
tongue, indicating that signals for axonal growth from our graft were lacking, or at 
least insufficient. 
 
 
5 PROGENITOR CELLS IN THE FILUM TERMINALE  
 
All of the results in this section were obtained from Paper IV. 
 
 
5.1 Distribution  
 
Sox2 and Mushasi-1 were applied on sagittal and/or coronal sections of the human 
filum terminale (FT). Sox2-immunoreactivity (IR) was abundant in the FT and 
labeled cells were found in the ependymal cell layer surrounding the central canal. 
Mushasi-1-IR was also detected in ependymal cells surrounding the central canal as 
well as in the subependymal compartment where cells were found in organized layers 
but also scattered in larger clusters at the surface of the FT. Cells positive for 
Mushasi-1 were also localized in smaller islets at a distance from the central canal. 
Mushasi-1 expressing cells were found to express Sox2 and cells expressing strong 
immunolabeling for Sox2 were found to express GFAP.  
In longitudinal sections from the rat FT we confirmed the presence of an ependymal-
cell-like lined central canal where the cells expressed Nestin. 
In the human the central canal in the FT displayed more of a scattered system of 
tubular structures lined by the ependyma, in contrast to the rat FT where the central 
canal was large and appeared better defined.  
 
 
5.2 In-vitro Characterization  
 
Single cells from the human FT tissue formed neurospheres in 13 out of 21 patients 
(62%). We observed that neurosphere formation was more frequent from young 
patient, showing excellent growth capacity allowing for up to 15-30 passages to be 
possible. Although we were also able to propagate cells from older patients the FT 
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tissue from here showed a lower growth rate when compared to the young (Figure 3, 
Table 4). Single cells isolated from the neurospheres were able to give rise to 
secondary neurospheres, thus demonstrating that at least some of the cells possessed 
self-renewal capacity. In cells at early stages Nestin immunolabeling was present. 
When allowed to differentiate we found that 5% of the cells expressed β-III-tubulin, 
this expression was validated in some of the patients for each expansion of the cells 
and found to be maintained for up to 29 expansions. When platelet-derived growth 
factor-BB (PDGF-BB) was added to the differentiation medium we observed a 
strong, almost tenfold, increase in the numbers of β-III-tubulin expressing cells. Upon 
differentiation also GFAP-positive cells with a morphology characteristic for 
astrocytes appeared.       
Rat FT cells were also cultured and we were able to obtain neurospheres from 5 out 
of 13 cultures (39%). However, due to the small amounts of harvested tissue, cells 
from rat FT was exceptionally difficult to expand, and thus to further analyze. 
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Figure 3. Quantitative determination of cell expansion from young donors (1-7 years) and old 
donors (42-60 years). (From Arvidsson, Fagerlund et al PLoS ONE 6(11), 2011). 
 
 
 
 
 
 
 
 
 
Table 4. Age of donors and the number 
of neurospheres formed. (From 
Arvidsson, Fagerlund et al PLoS ONE 
6(11), 2011). 
 
 
 
 
 
 
 
Age group n spheres no spheres 
1-5 8 6 2 
6-15 8 4 4 
>30 5 3 2 
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DISCUSSION 
 
 
 
 
 
 
 
 
 
Before summarizing the conclusions in Roman numerals the following section will 
discuss the findings and why certain conclusions can be made. The discussion will be 
both specific and general. I will also within this part include some methodological 
concerns that should not be neglected, and elaborate on future perspectives.  
The discussion aims at integrating all of these components.  
 
 
1 INTRODUCTION TO DISCUSSION 
 
In the first three papers (Papers I, II and III) we studied the fate of adult endogenous 
and grafted neural progenitor cells (NPCs) in the CNS after peripheral nerve injury. 
The overall aim was to challenge the hypothesis that endogenous or grafted NPCs will 
respond to degenerative events in their microenvironment directing their fate towards 
replacing lost cells.  
The scientific approach used to test the hypothesis is based on two different models of 
axotomy (transection vs. avulsion) of the hypoglossal nerve (n.XII) that generates 
fundamental differences concerning cell death of affected motor neurons. Transecting 
(cutting) the hypoglossal nerve using a pair of fine scissors in the periphery cause only 
modest neuronal degeneration in contrast to avulsion injury that induces massive cell 
death in the ipsilateral hypoglossal nucleus (nucl.XII) in the brainstem. 
 
We found a significant activation of endogenous as well as grafted NPCs in terms of 
proliferation, migration and differentiation following n.XII avulsion injury. However, 
the cells remained silent following a transection injury. These findings support the 
hypothesis that degenerating neurons are part, of what is likely a series of events, 
which eventually results in formation of signaling cues triggering the response of the 
NPCs. Alternative explanations could be related to co-variables like 
neuroinflammatory events that are more pronounced following avulsion injury.  
The activation of the NPCs most likely depends on both levels of cell degeneration, 
death and neuroinflammation which are closely interrelated and together contribute to 
form a highly complex microenvironment in the affected region.  
The rational for using the hypoglossal nerve system for these experiments is based on 
several issues. First, the n.XII is well characterized with regards to events occurring 
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in the peripheral nerve as well as in the corresponding nucleus in the brainstem after 
axotomy. These biological events varies depending on the type of injury etc. (see 
introduction), but includes always, at least to some degree degeneration and death of 
motor neurons, glial responses and neuroinflammatory events.  
Thus, the hypoglossal system as an experimental arena is well characterized and 
established and frequently used to investigate degeneration and regeneration in the 
nervous system in-vivo (Aldskogius et al. 1980; Aldskogius et al. 1984; Snider and 
Thanedar 1989; Svensson 1993; Svensson et al. 1995; Yu 1997; Itoh et al. 1999; 
Jiang et al. 2000; Toyoda et al. 2006).  
Furthermore, the nucl.XII is positioned in immediate vicinity to the central canal and 
fourth ventricle in the brainstem, with short distance to the ependymal region with the 
residing NPCs. Therefore, this experimental setup allows for studying the role of 
degenerating neurons on adult NPCs in the CNS following a peripheral nerve injury 
in-vivo. An area in which little is known. 
 
The precise nature of the immature cells in the ependymal region of the central canal 
and fourth ventricle that are referred to as NPCs in this study is still controversial and 
debated in the literature. Although it appears that ependymal cells, which during 
normal conditions are quiescent, are not the true stem/progenitor cells from which all 
adult neurogenesis has it origin, cells in the ependymal region throughout the adult 
CNS definitely have progenitor cell characteristics in the sense that they can be 
activated upon injury and disease and give rise to neurons, oligodendrocytes and 
astrocytes (Doetsch et al. 1999; Johansson et al. 1999; Namiki and Tator 1999; 
Brundin et al. 2003; Mothe and Tator 2005; Danilov et al. 2006; Coskun et al. 2008; 
Meletis et al. 2008; Carlen et al. 2009; Cizkova et al. 2009; Foret et al. 2010).  
 
To identify the NPCs we used markers that are expressed by stem/progenitor cells 
during development; Sox2 and Nestin (Hockfield and McKay 1985; Dahlstrand et al. 
1995; Bylund et al. 2003; Graham et al. 2003). In the adult there is no single 
exclusive marker for the stem/progenitor cells, but these two are considered to be 
expressed also in the adult CNS by NPCs, as defined in this study, and together with 
Mushasi-1 were the markers we used for identifying the neural progenitors (Doetsch 
et al. 1997; Kaneko et al. 2000; Filippov et al. 2003; Ellis et al. 2004; Komitova and 
Eriksson 2004; Baer et al. 2007).  
Although we did not fully characterize the cells, as we for example did not use other 
markers or electron microscopy, we considered the cells to be NPCs. 
Furthermore we cannot specify the exact identity and true nature of the subventricular 
zone (SVZ) NPCs that we harvested from the lateral ventricle wall; these could very 
well be the type B SVZ astrocyte-like cell, ependymal cells or also to some extent the 
type C cell. And, of course also a combination of these cell types. However, again the 
cells possessed NPC features as defined for the investigations in this study. 
 
Hypoglossal nerve injury is not often seen in clinical practise although it occurs 
occasionally following tumour surgery, trauma etc (Jung et al. 2010; Oyama et al. 
2012; Santis et al. 2012). However, the main aim of this part of the study was to 
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investigate, assess and evaluate the neurobiological events with regards to NPC 
activation after a motor nerve injury. Importantly though, with reference to clinical 
implications, the model can be considered to be comparable to a ventral nerve and 
root axotomy, thus making the neurobiological phenomena we observed clinically 
highly relevant and applicable to the often devastating ventral root avulsion injuries 
(Havton and Carlstedt 2009).  
 
 
2 ENDOGENOUS PROGENITOR CELLS 
 
 
2.1 Distribution 
 
We found abundant expression of Sox2 in the ependymal region in the central canal 
and fourth ventricle along the rostro-caudal extent of the nucl.XII.   
Sox2 has been elaborated on earlier; however since it is a key marker in this study 
some further discussion is warranted.  
The Sox proteins (Sex Determining Region of Y chromosome (SRY)) are HMG-box
Lefebvre et al. 2007
 
related, that is they belong to the High Mobility Group family of proteins that act as 
transcription factors which all have similarities within their HMG domain DNA-
binding sequence ( ; Chew and Gallo 2009). More than twenty 
different Sox proteins have been found and based on the similarities within the HMG 
domain they are divided in nine groups (A-H) (Lefebvre et al. 2007; Chew and Gallo 
2009). The B1 group contains Sox1, Sox2 and Sox3 which are shown to have 
importance in specification and maintenance of cells in a neural stem or progenitor 
cell state during development, but importantly also in the adult CNS (Bylund et al. 
2003; Graham et al. 2003; Ellis et al. 2004; Komitova and Eriksson 2004; Baer et al. 
2007). Other Sox proteins play important roles in further specification, such as the 
Sox4, Sox11 and Sox12 proteins, which have been demonstrated to be important for 
the establishment of neuronal properties, and the Sox 8, 9 and 10 proteins which are 
involved in regulation and formation of oligodendrocytes and Schwann cells i.e. 
myelinating cells (Bergsland et al. 2006; Dy et al. 2008; Chew and Gallo 2009).  
We chose Sox2 as a marker since it is shown to be expressed in neural stem or 
progenitor cells from very early on in development and prevails in the adult CNS as it 
is continuously expressed in the adult NPCs, which also the Sox1 and Sox3 proteins 
are (Ellis et al. 2004; Komitova and Eriksson 2004; Baer et al. 2007; Wegner 2011). 
However, Sox2 is one of the more extensively studied.  
By no means is one single transcription factor in control of cell fate decisions and 
differentiation, instead several different transcription factors from various families 
interact. Importantly though, the Sox proteins have a key role in keeping cells in an 
NPC state, controlling differentiation and cell fate and appear to be of paramount 
importance in coordinating the sequential gene expression in neurogenesis (Bergsland 
et al. 2011; Wegner 2011). Notably, it is also one of the transcription factors, together 
with a set of others, that has the ability to re-establish pluripotent cell characteristics 
in cells that are terminally differentiated (Takahashi and Yamanaka 2006). 
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We demonstrate that Sox2 expression was not only confined to cells in the ependymal 
layer, but we also detected several cells located in deeper layers that were expressing 
Sox2. These findings are supported by others, and it appears that not only cells in the 
ependymal layer of the central canal are Sox2 positive, but also cells in a SVZ 
resembling subependymal layer (Hamilton et al. 2009; Foret et al. 2010).  
This region of the CNS does not contain a SVZ of the same dignity as in the 
forebrain, but there is a layer of cells subependymal to the central canal lining which 
interestingly has also been found in humans (Doetsch et al. 1997; Dromard et al. 
2008). Thus a SVZ-like niche is present also within here (Hamilton et al. 2009).  
Quantification of Sox2 expressing cells revealed a difference in NPC numbers 
between the ventral, middle and dorsal parts of the central canal. Significant more 
Sox2-positive cells were found in the dorsal and middle regions when compared to 
the ventral part. Furthermore, avulsion injury induced proliferation in the ependymal 
layer which was also confined to the more dorsal parts of the central canal, i.e. not 
ventral. This dorsal to ventral gradient has been found also by others were the 
majority of proliferation markers were expressed dorsally, both in the ependymal as 
well as in the subependymal layer, although the majority of dividing cells were 
located in the ependymal layer (Hamilton et al. 2009). However, some report on an 
equal distribution of dividing cells for example after spinal cord injury, and others 
that the majority of proliferative cells are instead found in the medial part of the 
central canal, i.e. not dorsal, after physiological stimulation (Mothe and Tator 2005; 
Cizkova et al. 2009).  
 
The difference in dorsal-ventral activity of the ependymal layer in the central canal 
could be correlated to the dorsal-ventral pattering during developmental neurogenesis, 
which is important for the production of different neuronal cells (Cizkova et al. 
2009). And importantly, as has been discussed previously within this thesis, 
regulation of adult neurogenesis shares several signaling pathways with neurogenesis 
in development (see introduction). During development the morphogen Sonic 
hedgehog (Shh) is secreted from the notochord and induces the floor plate of the 
neural tube (Ulloa and Briscoe 2007). This initiates ventralization and a concentration 
gradient of Shh is produced that induces the formation of different progeny by a 
concentration and time dependant mechanism. The cells of the floor plate eventually 
also express Shh, and the highest levels of Shh are found in the ventral part. Within 
here five separate neuronal progenitor domains are formed, which gives rise to motor 
neurons and interneurons, but also has a critical role in the development of 
oligodendrocyte precursors (Dessaud et al. 2008).  
Furthermore, in dorsal-ventral patterning, the Bone morphogenic proteins (BMPs) 
secreted from the ectoderm leads to the formation of the roof plate. BMP is expressed 
also in the roof plate and the BMPs are found in the dorsal part, hence the 
concentration is highest here. This signaling has an important role in dorsal-ventral 
axis patterning, and together with Shh the dual morphogen gradient specifies different 
subclasses of neurons depending on their dorsal-ventral position and the 
concentration of Shh and BMP (Ulloa and Briscoe 2007). BMP thus promotes dorsal 
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patterning and formation of dorsal phenotypes such as sensory interneurons. 
However, BMP signaling is exceptionally complex, with a large number of functions 
in neural stem/progenitor cell fate and differentiation at several stages of neural 
development, therefore the effects differs with and are also tightly regulated in space 
and time (Bond et al. 2012).  
Shh and BMP signaling are active and have important functions also in adult 
neurogenesis. Shh promotes proliferation and maintenance of the neural precursor 
cell (Ahn and Joyner 2005; Favaro et al. 2009). BMPs and their signaling systems are 
involved in and act as regulators of self-renewal, proliferation and differentiation of 
NPC contributing to the maintenance of a neurogenic niche in the adult (Lim et al. 
2000; Quadrato and Di Giovanni 2012).  
It is difficult to specify exactly what this dorsal-ventral differences we, and others, 
have observed means in the adult. It appears however, that in this region activity upon 
injury does not involve extensive proliferation of the part that during development 
give rise to motor neurons i.e. the ventral region (Ulloa and Briscoe 2007).  
 
 
2.2 Proliferation 
 
Assessing proliferation has been of fundamental importance for the acceptance of 
adult neurogenesis, and although not fully recognised at that time, it was by the use of 
radioactively labeled Thymidine which integrates in the DNA during mitosis Joseph 
Altman showed that new neurons were formed also in the adult CNS (Altman 1963; 
Altman and Das 1965). Since then adult neurogenesis has gained general acceptance 
and strongly contributing to this are technical developments. In this, the application 
of the BrdU method, as we used, in proliferation assays is one strongly contributing 
factor.  
BrdU, or 5-Bromo-2´-deoxyuridine, is a Thymidine analogue which is incorporated 
in the DNA of dividing cells during the S-phase of the cell cycle, and is a robust 
marker for proliferation (Kee et al. 2002). As it is an exogenous agent it has to be 
administered to the experimental object by which follows uncertainties regarding 
levels of concentration, and also potential side effects such as cytotoxicity (Kee et al. 
2002). Because of this, it is possible that the numbers of proliferating cells are not 
adequate, although if erratic they are most likely underestimated. Not to be forgotten 
though is that it has been found to also label cells undergoing DNA repair, i.e. not 
dividing cells and this, the above and also other aspects has to be kept in mind when 
using BrdU (Kuhn and Cooper-Kuhn 2007). However, there is no doubt that BrdU is 
indeed useful and since the incorporation into the DNA is brought on to the daughter 
cells, it can also be used to trace cells.  
 
In accordance with the quiescent nature of the ependymal cells we only occasionally 
detected BrdU-incorporation in our controls (Coskun et al. 2008; Meletis et al. 2008; 
Carlen et al. 2009; Barnabe-Heider et al. 2010).  
The transection injury did not induce an increase in proliferative activity in the 
ependymal layer, indicating lack of or insufficient signals.  
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This was in contrast to the avulsion injury which induced a significant increase in 
proliferation. We show that there is a temporal profile in this proliferation which 
reflects both the need for self-renewal, thus maintaining a pool of NPCs in the niche, 
as well as producing glial progeny that for example contribute to the formation of the 
glial scar after CNS injury, contributing to tissue integrity (Namiki and Tator 1999; 
Mothe and Tator 2005; Meletis et al. 2008; Cizkova et al. 2009; Barnabe-Heider et al. 
2010).  
It is well documented that the ependymal cell can respond to injury with quite a 
dramatic increase in proliferative activity, should the stimulus be strong enough and 
that a more prominent stimulus induces a more excessive ependymal cell response in 
the central canal region (Meletis et al. 2008; Cizkova et al. 2009; Barnabe-Heider et 
al. 2010; Foret et al. 2010). However, it is also suggested that an even stronger 
stimulus, e.g. more severe injury, does not necessarily elicit a more intense response 
(Namiki and Tator 1999). As long as the injury or disease is severe enough to reach 
the threshold for signals to induce activation, the cells respond.  
Both of these two findings can be considered to support our findings on transection 
vs. avulsion and the influence on ependymal layer cells (Namiki and Tator 1999; 
Cizkova et al. 2009; Foret et al. 2010). To be mentioned is that also non-glial cells 
contribute to the scar formation and it is becoming clearer that pericyte derived cells 
have an important role here (Goritz et al. 2011). 
 
 
2.3 Migration and Differentiation 
 
In order to fully study NPC activation in the brainstem ependyma including migration 
and differentiation from the ependymal region, we obviously needed to be able to 
follow the cells as migration and differentiation proceeded, by other means than by 
BrdU-incorporation and intrinsic marker expression as the dynamic in gene 
transcription would change the phenotypic characteristics of the cell.  
Due to the direct contact of the brainstem ependyma NPCs with the cerebrospinal 
fluid (CSF) we were able to mark the progenitors by an intrathecal injection of the 
lipophilic dye DiI.  
One could argue that the use of DiI for the use of migratory and differentiation 
assessments is to some extent uncertain as, for example, cell to cell transfer of the dye 
from the ependymal layer cells would result in staining of other cells thus leading to 
misinterpretations of the findings. This is of course possible, however previous 
researchers have elaborated on this issue and found such a phenomenon not so likely, 
and there are several papers on the use of DiI as a method for labeling of cells for the 
same purpose as ours (Johansson et al. 1999; Brundin et al. 2003; Mothe and Tator 
2005; Danilov et al. 2006).  
Obviously, other methods are available and maybe superior, such as retroviral 
labeling, or the use of transgenic animals with reporter expression of certain specific 
markers (Johansson et al. 1999; Meletis et al. 2008). However, also these techniques 
come with considerations when interpreting results, as recombination is seldom 
complete thus making recombination efficacy important.    
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In addition to proliferation, the avulsion injury induced migration of DiI-labeled 
ependymal layer cells to the ipsilateral nucl.XII. 
 
Chemotactic signaling systems have been shown to be active also in the brainstem 
nuclei, including the nucl.XII, after a motor nerve axotomy (Harrison et al. 1998; Ji et 
al. 2004). Microglia express the chemotactic cytokine (chemokine) receptor CXCR4 
which is the receptor for the chemokine SDF-1α (Tanabe et al. 1997). Interestingly 
CXCR4 has been found on NPCs in the adult CNS and CXCR4/ SDF-1α signaling is 
involved in the migration of NPCs (Tran et al. 2004; Thored et al. 2005; Kokovay et 
al. 2010).  
This correlates to our findings where we show a time dependant migration of NPCs 
from the ependymal layer concomitant with an increase in expression of SDF-1α in 
the nucl.XII ipsilateral to nerve avulsion.  
In our study we encountered the SDF-1α in GFAP expressing cells of astrocytic 
morphology, which has been found also by others (Xu et al. 2007; Moll et al. 2009). 
There are however reports stating that cells in the ependyma are negative for CXCR4 
and that SDF-1α/CXCR4 signaling is not likely to mediate attraction of ependymal 
layer, or their progeny, cells at least in a spinal cord lesion (Meletis et al. 2008).  
 
Upon migration to the nucl.XII the endogenous NPCs differentiated into cells of 
astrocytic lineage but we were not able to detect neuronal differentiation.  
This gliogenic fate of the ependymal layer cells is well documented and it seems that 
the microenvironment in this region favors glial instead of neuronal differentiation in 
response to injury (Johansson et al. 1999; Shihabuddin et al. 2000; Brundin et al. 
2003; Mothe and Tator 2005; Meletis et al. 2008; Cizkova et al. 2009). However, 
although endogenous neurogenesis mostly seem to fail in this region the ependymal 
layer NPCs of the central canal are found to have the capacity to form neurons upon 
stimuli (Danilov et al. 2006). Interestingly, in this report on an experimental model of 
multiple sclerosis (experimental autoimmune encephalomyelitis (EAE)) neurogenesis 
appears to have been generated from the dorsal parts, in proximity to where the area 
of neuroinflammation was found i.e. the dorsal column. And, although speculative, as 
we also report on a dorsal-ventral polarization in proliferation, it could be so that 
signals for ventral central canal ependymal layer cell activation in response to 
avulsion injury are lacking or insufficient. Therefore no NPCs patterned for motor 
neuron differentiation were activated, and hence we did not find markers for newly 
formed neurons.  
 
To summarize this part, although we failed to show neurogenesis, we demonstrate 
that this cell pool is activated after avulsion injury including proliferation, migration 
and glial differentiation after avulsion injury. Another component indicating 
activation in the study was our, and others, finding that Nestin is re-expressed in the 
ependymal layer after injury. This probably reflects the stem/progenitor cell feature of 
these cells (Dahlstrand et al. 1995; Frisen et al. 1995; Namiki and Tator 1999; Mothe 
and Tator 2005; Foret et al. 2010). Again, this was seen only after avulsion of the 
n.XII. Therefore our findings clearly show that activation of the endogenous NPCs in 
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the ependymal layer of the central canal and fourth ventricle occurred after avulsion 
injury only, not transection.  
 
 
3 GRAFTED ADULT PROGENITOR CELLS 
 
Transplanted adult SVZ NPCs were found to respond more promptly to a severe 
n.XII injury. Thus, the results on grafting were consistent with the findings on 
endogenous NPCs as both were activated in a more extensive way after avulsion. 
Importantly though, the grafted cells differentiated also to neurons and appeared to 
have integrated with the host neurons. Furthermore, the SVZ NPCs exerted a striking 
beneficial effect on motor neuron numbers in the nucl.XII after avulsion injury. 
Significant more motor neurons were present at both 28 days and 3 months after 
injury post transplantation when compared to controls. This effect was not found after 
grafting to transected animals. 
In order to evaluate whether this truly was attributable to the transplanted cells we 
performed experiments where cell medium only, i.e. no NPCs, was injected into the 
nucl.XII after axotomies.  
Cell medium injections had no effect on motor neuron survival. We therefore 
concluded that the increase in motor neuronal numbers was attributable to the 
transplanted SVC NPCs.  
There could be two principally different explanations for this, either by the formation 
of new motor neurons from the grafted cells, i.e. direct cell replacement. Or, by a 
neuroprotective effect, a so called bystander effect (De Feo et al. 2012). In the former 
we would have found evidence for differentiation of NPCs to motor neurons in the 
nucl.XII, and although we found neuronal differentiation we could not detect motor 
neuronal markers in eGFP NPCs. Neither could we detect eGFP in cells with motor 
neuron profiles. Therefore, we concluded that the significant increase in motor 
neurons had to be due to a neuroprotective effect by the production of growth and/or 
immunomodulating factors (De Feo et al. 2012).  
 
We found that grafted NPCs expressed both the antioxidant enzyme glutathione 
peroxidase 1 (GPx1) and the growth factor vascular endothelial growth factor 
(VEGF).  
The intense GPx1 expression in transplanted adult SVZ NPCs seem to reflect these 
cells protective alertness, and is probably crucial for their survival in a 
microenvironment with ongoing and extensive cell degeneration that follows a severe 
injury with local accumulation of free radicals and oxidative stress. And, in part 
explains the effect on motor neuron survival that we demonstrate.  
In traumatic injuries and inflammatory disease of the nervous system there is 
activation and proliferation of microglia, also after a motor nerve injury, and 
abundant production of nitric oxide (NO) (Novikov et al. 1995; Novikov et al. 1997; 
Yu 1997; Aldskogius 2001; Moran and Graeber 2004). Although we did not directly 
investigate levels of NO we found an intense expression of GPx1 not only in grafted 
cells, but also widely distributed in the nucl.XII after avulsion. After transection the 
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expression was low, in accordance to the low levels of motor neuron degeneration 
and death in this injury.  
 
The GPx1 expression correlates to levels of oxidative stress as transcription and 
expression of the GPx1 gene and enzyme presumably is higher with increasing levels 
of inflammation, microglia activation and NO production i.e. in an on behalf of the 
motor neuron hostile environment.   
The correlation is not absolute, obviously, but the free radical NO and the effects it 
has is largely mediated through reactive oxygen species (ROS), reactive NO species 
(RNOS)  and free radicals thus high levels of GPx1 is likely to reflect high levels of 
free radicals (i.e. NO) and ROS i.e. oxidative and nitrosative stress (Doherty 2011). It 
might be appropriate to make the notion than in most studies, and those cited herein, 
it is not actually the levels of NO that have been measured but the levels of 
expression of the enzyme nitric oxide synthase (NOS) where the neuronal form 
(nNOS)  is constitutively expressed while the inducible form (iNOS) is expressed 
during pathological conditions (Doherty 2011; Lubos et al. 2011).  
 
We suggest that the GPx1 expression contributed to the bystander effect we 
demonstrate by the adult SVZ NPCs. In addition to this, the VEGF expression in 
these cells most likely had an impact on motor neuron survival by a neuroprotective 
effect.  
On the neuron VEGF is shown to promote axonal outgrowth (Sondell et al. 2000). 
Furthermore, it is also well documented that VEGF has a neuroprotective effect on 
motor neuron degeneration in motor neuron disease (Azzouz et al. 2004; Xu et al. 
2006; Tolosa et al. 2008). And, in addition, VEGF is expressed in axotomized motor 
neurons and found to provide neurotrophic support as an increase in the survival of 
motor neurons has been observed (Skold et al. 2000; Skold et al. 2004; Pereira Lopes 
et al. 2011).  
The VEGF family of proteins and their receptors has been shown not only to be 
important in motor neuron survival, but they are also found to be intimately involved 
in regulation and promotion of neurogenesis and are part of the unique neurogenic 
microenvironments, niches (see introduction) (Jin et al. 2002; Carmeliet 2008; 
Riquelme et al. 2008; Ekdahl 2012).  
 
Motor neurons respond also to other growth- and neurotrophic factors such as neural 
growth factor (NGF), brain-derived neurotrophic factor (BDNF) and glial cell line-
derived factor (GDNF). Both BDNF and GDNF have been found to prevent motor 
neuron cell loss after ventral root avulsions, and GDNF also to promote axonal 
outgrowth from motor neurons (Novikov et al. 1995; Tuszynski et al. 1996; Novikov 
et al. 1997; Wu et al. 2003; Llado et al. 2004; Rodrigues Hell et al. 2009; Su et al. 
2009).  
Importantly NPCs have been found to express growth factors such as NGF, BDNF 
and GDNF (Lu et al. 2003; Llado et al. 2004; Su et al. 2009; Foret et al. 2010).  
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Other growth factors are also expressed by, and involved in the modulation of, NPCs 
and for example platelet-derived growth factor PDGF is reported to be of importance 
in the regulation of neurogenesis (Erlandsson et al. 2006; Ishii et al. 2008). 
In our experiments we show that NPCs from the lateral ventricle wall of adult rodents 
express VEGF both in-vitro, and after transplantation to the nucl.XII.  
 
 
4 ACTIVATION OF THE PROGENITOR CELLS 
 
There are some conflicting results on NPC response to the n.XII avulsion injuries in 
our study. The ependymal region NPCs did not differentiate into neurons and did not 
have a neuroprotective effect on avulsed motor neurons. One would expect the same 
signaling pathways to be active in the nucl.XII in response to equipotent injuries. 
Therefore, the signals that induced neurogenesis and integration of SVZ NPCs should 
also be present and available for the endogenous ependymal layer NPCs.  
One explanation for this difference could be differences in cell characteristics and 
responsiveness to the available signals and cues. 
As discussed above on endogenous ependymal NPCs in the central canal most report 
on gliogenic differentiation after injury or disease, without formation of cells 
expressing neuronal markers (Johansson et al. 1999; Brundin et al. 2003; Mothe and 
Tator 2005; Meletis et al. 2008; Cizkova et al. 2009; Foret et al. 2010). But, as 
mentioned, they do possess neurogenic capabilities as neurogenesis from these cells 
has been reported in EAE and also after spinal cord injury when growth factors were 
added intrathecally (Kojima and Tator 2002; Danilov et al. 2006). In addition, cells 
from caudal levels i.e. spinal cord have the ability to differentiate into neurons in-
vitro and upon transplantation to known neurogenic regions (Weiss et al. 1996; 
Shihabuddin et al. 2000). Although, in these reports it was not specified from exactly 
which niche in this part of the CNS the progenitor cells came from. Furthermore, the 
microenvironment created in the nucl.XII after avulsion apparently contained signals 
that induced the adult SVZ NPCs to form neurons, integrate and protect.  
 
Except for maybe a gliogenic nature of the ependymal NPCs in the brainstem, or that 
there were actual differences in the niche between the experiments, other plausible 
explanations for our findings exist.  
First, the survival time was longer in the transplantation experiments (3 months as 
compared to 28 days) and if extended in time it is possible that we would have found 
neuronal markers also on cells that originated from the endogenous NPCs. Also, there 
are fundamental differences in the constitutions of these two regions. The cell 
composition in the SVZ of the lateral ventricle wall is heterogeneous, including both 
quiescent and more rapidly dividing progenitors or precursors and here a continuous 
ongoing neurogenesis prevails (Ihrie and Alvarez-Buylla 2011).  
In the central canal and fourth ventricle region it is the ependymal cell that is the 
NPC, which is considered quiescent. It divides slowly and only in order to maintain 
the NPC population, thus not giving rise to differentiated progeny during normal 
physiological conditions (Meletis et al. 2008; Cizkova et al. 2009; Barnabe-Heider et 
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al. 2010; Foret et al. 2010). Although the ependymal cell of the forebrain SVZ is also 
considered quiescent during non-pathological conditions, this region contains other 
proliferative cells (Coskun et al. 2008; Carlen et al. 2009). And, as we did not in 
detail characterize the cells we harvested from the lateral ventricle wall the NPCs we 
grafted could very well be ependymal cells, SVZ type B astrocytes and/or the type C 
cells. Furthermore, the cells we transplanted were contained in cell culture medium, 
including growth factors as described, and this could also have had a beneficial effect 
on the transplanted SVZ NPCs favoring survival, differentiation and integration.  
Also, there were differences in animal strains which could explain differences in the 
niche in the nucl.XII after avulsion and hence different signals or different levels of 
signals. It is well documented that variations in genetic factors in the same species but 
different strains can influence e.g. inflammatory levels after injury with effects on 
outcome (Popovich et al. 1997; Sroga et al. 2003; Swanberg et al. 2006; Piehl et al. 
2007).  
 
Nonetheless, despite these differences and possible explanations for them, both 
endogenous and transplanted NPCs were activated after a severe motor nerve injury 
i.e. avulsion but not after transection. And, if now, which could be considered 
efficient, activation of NPCs is related to the level of injury and hence the assumable 
need for induction of NPCs in order to repair and replace neurons and other 
components lost, what are the actual signals involved?  
 
The neural stem or progenitor cells in the neurogenic regions in the adult CNS are in 
a microenvironment, or niche, where the milieu created by the NPCs and surrounding 
cells (i.e. astrocytes, ependymal cells, interneurons, microglia, oligodendroglia, 
perivascular cells, fibroblasts) and components such as diffusible signals and 
molecular factors in intrinsic and extrinsic signal pathways, extracellular matrix 
proteins, gap-junctions, basal lamina and the vasculature, where angiogenesis and 
neurogenesis for example share some factors (e.g. VEGF (Jin et al. 2002)), constitutes 
a permissive setting which continuously allows for and regulates neurogenesis thus 
determining NPC fate (Gritti and Bonfanti 2007; Riquelme et al. 2008; Ihrie and 
Alvarez-Buylla 2011; Morrens et al. 2012).  
 
Many of the signals involved in regulation and activation in adult NPCs are as stated 
of course also found during development where several of them have multiple or at 
least dual functions.  
Epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) are two of 
the most established mitogens with regards to propagation and proliferation of adult 
NPCs, not only under cell culture conditions but also in-vivo as the EGF receptor has 
been found in the SVZ and infusion of both of these two mitogens shown to promote 
proliferation of NPCs (Reynolds and Weiss 1992; Morshead et al. 1994; Craig et al. 
1996; Reynolds and Weiss 1996; Kuhn et al. 1997; Kojima and Tator 2002; Martens 
et al. 2002).  
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In addition there are a number of important signals and signaling pathways in the 
regulation of NPCs. The Notch signaling pathway is involved in keeping cells in a 
stem or progenitor cell state thus inhibiting neurogenesis (Stump et al. 2002). The 
basic helix loop helix (bHLH) family of proteins can either promote neurogenesis or 
be inhibitory and mediate self-renewal or induce astrogliogenesis (Kageyama et al. 
2005). Furthermore, the Janus kinase (JAK) / Signal transducer and activator of 
Transcription 3 (STAT3) pathway, where LIF and Ciliary neurotrophic factor 
(CNTF) are two of the most important signaling molecules, is found to be of 
importance in the self-renewal of NPCs and neurogenesis in the adult, while 
downregulation of STAT3 blocks neurogenesis (Quadrato and Di Giovanni 2012). 
Also of major importance, as extensively discussed previously, are the Sox proteins 
and the Shh and BMP signaling systems. 
 
How injury and disease affect these factors and signaling pathways has not to date 
been fully characterized, and we did not in detail examine which factors that on a 
molecular level are involved in the activation of the endogenous and grafted NPCs. 
However, the level of motor neuron cell loss was strongly correlated to the activation 
of both the endogenous NPC pool and the transplanted SVZ NPCs with regards to 
proliferation, migration, differentiation and integration.  
We confirm previous findings, and differences, with regards to motor neuron cell loss 
but also to the inflammatory and glia cell reactions seen after transection and avulsion 
injuries (Svensson and Aldskogius 1993; Koliatsos et al. 1994; Yu 1997; Itoh et al. 
1999; West 1999; Jiang et al. 2000; Hoang et al. 2003).  
These observations were consistent throughout the study with regards to levels of 
motor neuron cell loss, which was substantially higher after avulsion injuries as 
compared to the transections. However, we did not evaluate levels of e.g. microglia 
and macrophages in the transplantation experiments and only assume that the levels 
of inflammation were equal to the levels and differences found in the endogenous 
NPC experiments. Importantly though, there are differences with regards to the 
inflammatory response between the two different animal strains used, the Sprague-
Dawley and the Lewis, therefore such conclusions has to come with precautions 
(Popovich et al. 1997). However, important to notice is that the transplantation 
experiments were primarily compared to each other, and here the same wild-type and 
transgenic animal strains were used.  
Also, we did detect differences in the levels of the antioxidant enzyme GPx1 in the 
nucl.XII in the transplantation papers, indicating differences with regards to 
inflammation between avulsion and transection also in these experiments (Lubos et 
al. 2011).  
We suggest that both motor neuron cell death and neuroinflammation creates a 
microenvironment, or niche, in the nucl.XII of which the constituents and/or the 
levels differ between avulsion and transection injury. And therefore the NPC response 
we report on differ in-between the two types of axotomies. 
 
Thus, it is plausible to discuss on mechanisms for activation with reference also to 
microglia and inflammation.  
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Interestingly, microglia and NO are found to be involved in the regulation of 
neurogenesis in the adult CNS and are shown to affect various signaling pathways 
regulating NPC self-renewal, proliferation, differentiation and integration 
(Contestabile and Ciani 2004; Ekdahl 2012). However, it appears that there are 
dichotomies in regards to the effects as for example neurogenesis can be both 
promoted and inhibited, it also appears as that the influence differs whether the 
conditions are normal or during inflammation (Ekdahl et al. 2009; Carreira et al. 
2012; Ekdahl 2012).  
It has been shown that high levels of NO decreases neurogenesis and promotes 
gliogenesis but also inhibits proliferation of NPCs of the SVZ, and that blocking of 
NO synthesis results in an increase of neurogenesis (Covacu et al. 2006; Romero-
Grimaldi et al. 2006; Torroglosa et al. 2007). It appears that during normal conditions 
NO blocks neurogenesis, keeping the NPCs in a progenitor cell state, but during 
injury and inflammation exerts a neurogenic effect on them - however with 
differences that are dependent on the type and severity of the injury (Carreira et al. 
2012).  
 
Microglia is found to have some detrimental effects on neurogenesis (Monje et al. 
2003; Iosif et al. 2006). However, the dual role of microglia in adult neurogenesis is 
becoming more evident, and microglia have been found to exert beneficial effects on 
NPC survival and proliferation, for example by chemokine signaling between neurons 
and microglia, and by production of growth factors (Iosif et al. 2006; Ziv and 
Schwartz 2008; Bachstetter et al. 2011; Ekdahl 2012).  
 
 
5 PROGENITOR CELLS IN THE FILUM TERMINALE 
 
The rationale and background for these experiments were the findings on both adult 
SVZ NPC grafting and the insufficient response in the endogenous NPCs after nerve 
avulsion injuries.  
Therefore the development of an autologous transplantation model was initiated.  
In order for this to be possible additional experimental work was needed and several 
criteria had to be fulfilled. First, we needed a potential tissue candidate where cells with 
NPC characteristics exist. Secondly, tissue from such an anatomical site would have to 
be readably accessible without too large risks associated with harvesting. Furthermore 
the tissue should not only contain NPCs, but cells from here would have to be possible 
to propagate in-vitro.  
Obviously also, the cells have to be able to survive grafting, differentiate and integrate 
in the injured region and/or produce factors favorable for regeneration and functional 
improvement.  
 
However, initially the first three criteria had to be elaborated on. With regards to these 
our lab has previously shown that it is possible to harvest SVZ NPCs from humans 
during endoscopic neurosurgical procedures (Moe et al. 2005; Westerlund et al. 2005). 
Although minimally invasive and considered a safe and well established neurosurgical 
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procedure this procedure involves brain parenchyma to be penetrated by the endoscope, 
and also, although successfully cultured, the cells from here have turned out to be very 
difficult to process. 
 
For these reasons we turned into other sources for cell harvesting. Since the central 
canal, lined by cells with NPC characteristics, has been found to extend caudally into 
the filum terminale (FT) where also glia cells, neurons and possibly immature neurons 
are found, we decided on to characterize this structure further (Choi et al. 1992; George 
et al. 2003; Rethelyi et al. 2004; Fontes et al. 2006).  
In addition, cells from the human FT have been demonstrated  to possess NPC features 
as they proliferated, formed neurospheres, self-renewed, expressed NPC markers and 
upon differentiation developed features characteristic for neurons, oligodendrocytes 
and astrocytes (Varghese et al. 2009). The cells were also grafted into an animal model 
of stroke and found to migrate to the lesion site and differentiate into astrocytes. 
However, no neuronal markers on grafted cells were observed in-vivo.  
 
A protocol for harvesting, characterization and culturing of tissue and cells from the 
human FT was developed.  
The tissue was obtained from donors undergoing the neurosurgical procedure of 
detethering of a teheterd spinal cord (Warf 2004; Fontes et al. 2006; Liu et al. 2011). 
We demonstrate that cells expressing Sox2 and Mushasi-1 are abundant and present 
throughout the entire length of the FT. Thus, this shows that it is not necessary to 
indentify a certain part of the FT for future therapeutic use, and also that if a reasonable 
part of it is resected it is likely that cells can be obtained in adequate numbers for 
grafting. Furthermore, Sox2 and Mushasi-1 expressing cells were not confined to the 
ependymal layer surrounding the central canal, but also subependymal organized bands 
and clusters of cells expressing NPC markers were observed. Interestingly, the 
distribution of NPCs in the FT demonstrated similarities to the findings reported on 
from human spinal cord, where NPCs are shown to be present also in a subependymal 
layer (Dromard et al. 2008).  
When taken to culture conditions we found that cells from the FT could be propagated 
and that they differentiated into neurons and astrocytes. The cells were found to behave 
in a similar manner as the adult SVZ NPCs. Furthermore, clonal expansion indicated a 
relatively strong self-renewal capacity.  
We observed differences in growth capacity as FT from younger donors were easier to 
expand and showed higher proliferative ability. This is in line with findings on adult 
NPCs where it is found that neurogenesis is decreased with higher age (Chen et al. 
2006; Luo et al. 2006; Encinas et al. 2011). Importantly though, we were able to show 
that the self-renewing properties were maintained also in tissue from adult older donors 
(> 30 years of age).  
 
In addition, we show that the FT NPCs respond to PDGF-BB with a significant (almost 
tenfold) increase in the amount of neuronal cells. PDGF signaling is important for self-
renewal and neurogenesis, both in the developing and adult nervous system, and this 
growth factor family is composed of five hetero- or homodimeric PDGF ligands and 
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three tyrosine kinase receptors (Fomchenko and Holland 2007). The PDGF-BB is 
shown to activate all three of the receptor isoforms i.e. αα, αβ and ββ (Williams et al. 
1997). It appears that the PDGF-BB ligand, together with the PDGF-AA and AB 
ligands, is primarily important for survival and proliferation of NPCs and immature 
neurons and not involved in fate determination (Johe et al. 1996; Williams et al. 1997; 
Erlandsson et al. 2006). Although it has been suggested that PDGF signals are also 
involved in neuronal induction (Johe et al. 1996).  
In the postnatal and adult CNS both the PDGF-α and β receptors have been found to be 
expressed by NPCs in the SVZ (Jackson et al. 2006; Ishii et al. 2008). Furthermore, the 
PDGF is considered to be a potent mitogen of oligodendrocyte precursor cells in the 
SVZ, and it is suggested that PDGF signaling balances neuron and oligodendendrocyte 
production from SVZ NPCs in cooperation with bFGF (Jackson et al. 2006; 
Fomchenko and Holland 2007; Rao et al. 2009). Importantly, there are some 
discrepancies on PDGF findings which could reflect differences in growth factor 
responsiveness during development and in the adult. 
However, our findings show that a NPC pool is maintained in the FT in the young and 
adult, and that cells from here can be induced to increase neuronal cell numbers upon 
administration of growth factors i.e. PDGF-BB. 
 
Adult NPCs and PDGF signaling is of importance also on discussions regarding tumor 
formation, and overexpression of PDGF ligands and receptors are involved in the 
development of tumors in the CNS (Fomchenko and Holland 2007).  
The connections between adult neurogenesis and tumors of the CNS are many, both in 
general conceptual views as well as in more specified details. Within cancer biology the 
concept of a cancer stem cell (CSC) has evolved recently. One of these models, the 
stemness phenotype model, proposes that there is a single CSC with different stem or 
progenitor cell properties depending on the microenvironmental constituents, which are 
detrimental, for the rise of multiple neural lineage phenotypes responsible for the 
heterogeneity of cells within a tumour (Cruz et al. 2012).  
This way of looking upon primary brain tumors is very much like the neurogenic niche 
concept of adult neurogenesis. Furthermore, many of the markers used for identifying 
NPCs are expressed by glial brain tumors e.g. Sox2, Nestin, Mushasi-1 and CD133 and 
it is suggested that at least the glioblastoma multiforme has it origin in oncogenic 
transformation of endogenous NPCs in the SVZ and changes in this niche. For example 
as discussed above by alterations in growth factor expression, receptors and signaling 
pathways (Quinones-Hinojosa and Chaichana 2007; Germano et al. 2010).  
Also ependymomas and medulloblastomas have been found to contain CSCs which 
exhibit NPC characterisistics involving the same signaling pathways for self-renewal 
and differentiation, including neuronal differentiation, giving rise to the heterogeneous 
population of cells also in these tumors (Andreiuolo et al. 2010; Aizawa et al. 2011; 
Manoranjan et al. 2012). 
Thus conducting experiments which involve comparing the NPCs and the CSCs may 
very well be one strategy to resolve some of the enigmatic features of both adult 
neurogenesis as well as brain tumor formation – perhaps resulting in the provision of 
new therapeutic instruments.  
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6 TREATMENT STRATEGIES AFTER AVULSION INJURIES 
 
A ventral nerve or root avulsion injury comes, as shown, with massive loss of motor 
neurons leading to devastating functional deficits (Koliatsos et al. 1994; Carlstedt et al. 
1995; Hoang et al. 2003; Havton and Carlstedt 2009; Carlstedt 2011). Furthermore, 
ventral root avulsion injury induces loss of autonomic neurons and intramedullary 
degeneration of sensory afferent axons and neuropathic pain (Hoang et al. 2003; Bigbee 
et al. 2007; Bigbee et al. 2008). 
Ventral root avulsion injuries in patients are most frequent in the cervical region, but 
occur also in the lumbar part, and are in the majority of cases the result of high energy 
trauma e.g. brachial plexus injuries after motor vehicle accidents (Narakas 1985; 
Havton and Carlstedt 2009). However, also complications during delivery are a major 
cause.  
Approximately 70% will have multiple roots avulsed and as many are likely to 
experience persisting pain, especially when there is affection of lower cervical roots 
(Narakas 1985). 
 
 
6.1 Endogenous Neural Progenitor Cell Activation 
 
The endogenous NPCs, although activated, did not differentiate into neurons. Neither 
did they appear to exert neuroprotective effects on the motor neurons in the nucl.XII. 
This does not per se exclude them from a possible fundamental role in motor neuron 
survival, and adult NPCs from the ependymal layer have been found to express BDNF 
after for example spinal cord injury (Foret et al. 2010). It could be that they do have the 
same nursing role as transplanted adult SVZ NPCs, meaning neuronal loss after 
avulsion would be even more substantial if they did not exist.  
This is however speculative with regards to our study, since we did not perform 
experiments on growth factor or scavenger production, neither were experiments where 
the NPCs in the ependyma were depleted and thereafter the nerve injured performed. 
Addition of growth factors could be one way to modulate the endogenous NPC 
response, in order for them to be candidates in treatments for injury and disease in the 
nervous system. There are reports of effects on endogenous NPCs in the central canal 
and fourth ventricle, and also in lesioned spinal cord after administration of growth 
factors (Kojima and Tator 2002; Martens et al. 2002; Ohori et al. 2006).  
The use of endogenous NPCs is an, in theory at least, attractive alternative to 
transplantations since many of the negative components of grafting do not apply. For 
example ethical issues with regards to the potential tissue for stem/progenitor cell 
harvesting, immunological considerations with graft-versus host reactions, the risk of 
inducing invasive malignancies i.e. tumour formation and of course the risks associated 
with the invasive procedure of grafting. 
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6.2 Grafting of Adult Neural Progenitor Cells 
 
The beneficial neuroprotective effects of transplanting adult NPCs on motor neurons 
after detrimental nerve injuries cannot be neglected.  
There are several reports on this neuroprotective effects by growth factor producing 
stem or progenitor cells. Importantly though, few report on NPCs and their role in the 
CNS after peripheral nerve injuries, and even fewer on transplantations of adult NPCs 
in these.  
 
Su and co-workers reported on a neuroprotective effect on motor neuron survival 
after grafting of NPCs post avulsion, where the effect was attributable to the 
production of growth factors from the NPCs (Su et al. 2009). They too, failed to 
demonstrate axonal growth from transplanted eGFP NPCs although they observe that 
grafts promote host axonal regeneration. The neurotropic effect of NPCs on motor 
neurons they report on is supported by others. Although in-vitro, it was found that 
motor neurons in spinal cord explants grew axons through the white matter to form 
new ventral root-like structures (Llado et al. 2004).  
However, and important, the transplanted cells in the Su paper were embryonal NPCs 
– not adult cells.  
 
Furthermore, mesenchymal stem cells from adult animals were grafted to the ventral 
horns after ventral root avulsion and demonstrated to have a neuroprotective effect 
similar to what we and the Su group report on (Rodrigues Hell et al. 2009).  
As far as I know, our study is the first report on the use of adult SVZ NPCs. 
Thus, transplantation of different types of stem or progenitor cells after motor nerve 
injuries resulting in massive motor neuron loss, i.e. nerve avulsion, has significant 
beneficial effects on motor neuron survival. Then the question is what cells to be used 
in future transplantations to our patients? 
 
When it comes to transplantations to the nervous system in general there is a plethora 
of experimental models, but also some clinical trials, which differs with regards to 
several factors (De Feo et al. 2012). These factors involve the injury or disease model 
used, the species and age of the host, whether the transplantation model used included 
allografting or xenografting and if a targeted direct approach was used with 
implantation in the region of cell loss, or if cells were grafted into other regions or even 
injected into the circulatory system demanding migration (Cummings et al. 2005; Parr 
et al. 2007; Lu et al. 2012; Lundberg et al. 2012; Riley et al. 2012).  
Furthermore, several different cells and cell lines have been used, both from human and 
animals, and also from different locations such as brain and spinal cord (Cummings et 
al. 2005; Lepore et al. 2006; Parr et al. 2007; Lu et al. 2012; Muneton-Gomez et al. 
2012; Riley et al. 2012). In addition, genetically engineered cells and cells primed for 
replacement of a specific cell type have been used (Bjorklund et al. 2003; Lu et al. 
2003). 
In most reports on grafting of NPCs embryonic or fetal cells have been used, but it is 
also suggested that cells from the adult CNS can be used in transplantations, both from 
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the brain and spinal cord (Pluchino et al. 2003; Westerlund et al. 2005; Parr et al. 2007; 
Parr et al. 2008). 
 
All of these transplantation strategies bring some obstacles that need to be addressed if 
they are to be used in the everyday clinical practice. A major limiting factor with 
embryonal or fetal tissue is tissue availability. But with such tissue obviously also 
ethical questions and the risk of infiltrative tumor formation, when using 
undifferentiated tissue with multi lineage differentiation potential, are of importance 
(Brederlau et al. 2006; Guillaume and Zhang 2008).  
In addition, as long as non-self tissue is grafted there is a risk of graft rejection which 
demands for immunosuppressant medication with several potential side effects, besides 
the obvious risk of losing all or the majority of grafted cells from a graft vs. host 
reaction (Rezzani 2006; Guillaume and Zhang 2008; Laguna Goya et al. 2011).  
To overcome some of the issues stressed above, for example availability and ethical 
considerations, mesenchymal stem cells have been used (Parr et al. 2007; Parr et al. 
2008; Rodrigues Hell et al. 2009). Although these cells might not be as promising as 
once suggested, beneficial effects are reported (Barnabe-Heider and Frisen 2008; 
Rodrigues Hell et al. 2009). 
 
However, taken together and despite the above discussed concerns cell transplantation 
strategies seem more promising than the use of endogenous NPCs.  
As we demonstrate abundance of growth factor responding NPCs in the human FT, 
also from older donors, we suggest that cells from here be used in autologous 
transplantations for nervous system repair. Such a repair model would succumb several 
of the issues raised on cell grafting. And, importantly, it is possible at least from a 
technical and logistical point of view to apply it to the clinical setting.  
 
 
6.3 Root and Nerve Implantations 
 
Reimplantation and implantation of peripheral nerve grafts for treatment of avulsion 
injuries is shown to have beneficial effects on motor neuronal and axonal regeneration 
in experiments (Carlstedt et al. 1993; Wu et al. 1994; Hoang et al. 2006; Su et al. 2009; 
Pinter et al. 2010). Interestingly, it seems that the beneficial effects after a root 
reimplantation is not confined to the one level of implantation, but effects are also 
observed on adjacent levels (Hoang and Havton 2006). In addition, experiments 
demonstrate that root reimplantation can improve the allodynia and sensory axon 
degeneration (Bigbee et al. 2007; Bigbee et al. 2008). 
The axonal regeneration from the CNS to the PNS is, at least partially, believed to be 
due to proliferating Schwann cells, which are associated with the implanted root or 
peripheral nerve graft and provide trophic support (Li and Raisman 1994; Wu et al. 
1994; Ide 1996; Cullheim et al. 1999; Chu et al. 2008; Chu and Wu 2009; Carlstedt 
2011).  
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6.4 Combinational Therapies 
 
As experimental root reimplantation, or nerve graft implantation, is found to have 
effects on the above, it is most definitely plausible to use this repair strategy in avulsion 
injuries. It has also been taken to the patients, and is a well established treatment of 
brachial plexus injuries with root avulsions (Carlstedt et al. 1995; Carlstedt et al. 2004; 
Havton and Carlstedt 2009; Carlstedt 2011). Although some functional improvement 
has been observed, additional treatments are needed in order to improve outcome. 
One strategy is to use a combined approach including both NPCs and root/nerve graft 
implantation. It has been found that after a ventral root avulsion both grafting of NPCs 
and implantation of a peripheral nerve graft have beneficial effects on motor neuron 
survival (Su et al. 2009). The neuroprotective effect was equal in both the group that 
received NPCs and the peripheral nerve graft group, without any significant differences 
in motor neuron survival and a combination of the strategies did not improve survival 
further. Thus no synergistic effect on motor neuron survival could be demonstrated. 
Importantly though, the combination of transplanted NPCs and nerve grafting promoted 
host axonal growth. Thus both neurotrophic and neurotropic effects were found and 
suggests a combinational strategy including NPC and root/nerve grafting.  
This has to be further evaluated in experiments.  
 
 
6.5 Timing of Treatment 
 
If to be taken to the patient, the timing of transplantation after motor nerve and root 
avulsion injuries is of importance.  
We found a beneficial effect on motor neuron survival in this study when transplanting 
the adult NPCs at nine days after avulsion. This was chosen as a time point not to late 
with regards to the progressive loss of motor neurons after an avulsion, and not to early 
as we reasoned that the environment immediately after injury would be less permissive 
for NPC survival and integration. 
On the other hand, transplantation at early stages after injury could in fact be more 
favorable by providing conditions more permissive for graft integration, and also for 
achieving early neuroprotective effects. However, when transferring ours and others 
experimental data to a clinical setting, nine to fourteen days is a clinically relevant time 
point. Clinically relevant because as approximated 70% of patients with severe root or 
avulsion injuries have multiple associated injuries (Narakas 1985). These are often life 
threatening conditions that demands imperative treatments, and the patient to be 
stabilized, before eventually a nerve avulsion injury can be treated. Furthermore, there 
is time needed for proper and accurate diagnostics of root avulsion injuries including 
both neuroradiology as well as neurophysiological investigations. And, importantly, 
cells for grafting must be harvested and expanded in culture before grafting.  
 
The experimental findings on the timing of NPC transplantations support this delayed 
or subacute regime, not only after motor nerve avulsion injuries, but also for example 
 58 
when grafting NPCs to spinal cord injuries (Okano et al. 2003; Parr et al. 2007; Lu et 
al. 2012).  
 
By the above follows also that grafting of cells should not be performed too long after 
avulsion injury and many of the experimental papers on root reimplantation after root 
avulsion support an acute reinsertion of the avulsed root due to the progressive motor 
neuron loss, which after 4 weeks is described to be at levels of 50-80%, well in line 
with our findings.  
Not to transplant in a chronic phase i.e. late is also supported by the findings that 
clinical restitution of activity after root reimplantation has been observed only in those 
patients that were operated upon within one month (Carlstedt 1997; Havton and 
Carlstedt 2009).  
 
 
7 CONCLUDING REMARKS 
 
Many of the signals- and signaling pathways involved in regulation and activation of 
adult neurogenesis are found during developmental neurogenesis. Interestingly, several 
of these “key players” of regulatory pathways are also involved in the regulatory 
machinery responsible for the events occurring after nerve injury with regards to motor 
neuron survival and death, but also with regards to repair after other injuries and 
diseases in the CNS (Kiryu-Seo and Kiyama 2011; Quadrato and Di Giovanni 2012). 
This can at least to some part be understood if seen as that the neurons affected change 
from an active signaling state to a more rudimentary, survival- and growth promoting 
state.  
Thus, in order for repair strategies with neural stem or progenitor cells aiming at 
regeneration and partial or full restoration of functional deficits in the nervous system, 
affecting not only motor nerve injuries as investigated in this thesis work, the 
understanding of these molecular mechanisms are fundamental.  
This can only be done by continuing with well designed and thought through 
experimental studies.  
 
To conclude, there are many issues to be further evaluated and questions to be 
answered, and although we are not even close to the beginning of the end for the 
experimental work on adult neurogenesis to be finished, in order for the findings to be 
brought to the patients, we are closer to the end of the beginning today than we were 
yesterday. 
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CONCLUSIONS 
 
 
 
 
 
 
 
 
 
I. In response to cell loss by nerve avulsion the ependymal layer cells in the brainstem 
regenerative zone of the central canal and 4th
 
 ventricle proliferated and the progeny 
cells migrated into the lesion area. The progeny formed astrocytes but no neurons.   
 
II. In this model of transplantation to immunocompetent animals grafted NPCs formed 
neurons that integrated with host neurons. As a bystander effect, the grafting procedure 
significantly improved the number of surviving motor neurons.  
 
 
III. The severe injury (avulsion) was significantly more permissive for survival, 
differentiation and synaptic integration of grafted NPCs. Cells grafted into the severely 
injured area up-regulated antioxidant and trophic mechanisms.     
 
 
IV. Neural progenitor cells are present in the human filum terminale, also in the adult. 
They are abundant and exist along the entire filum terminale. Similar to the SVZ NPCs 
they form neurospheres and can be propagated in culture. Upon differentiation they 
express markers for neurons and glia. Administration of PDGF-BB results in an 
increase in neuronal cell numbers. Thus this supports their potential use as candidate 
cells in future transplantation models.   
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